Document:

exv4w2

 

EXHIBIT 4.2

EXECUTION VERSION

REGISTRATION RIGHTS AGREEMENT

     REGISTRATION RIGHTS AGREEMENT, dated as of June 27, 2007, among Dollar Financial Corp., a
Delaware corporation (together with any successor entity, herein referred to as the “Company”),
Wachovia Capital Markets, LLC and Bear, Stearns & Co. Inc., as representatives (the
“Representatives”) of the several initial purchasers (the “Initial Purchasers”) under the Purchase
Agreement (as defined below).

     Pursuant to the Purchase Agreement, dated June 21, 2007, among the Company and the
Representatives (the “Purchase Agreement”), relating to the initial placement (the “Initial
Placement”) of the Notes (as defined below), the Initial Purchasers have agreed to purchase from
the Company $200,000,000 in aggregate principal amount of 2.875% Senior Convertible Notes due 2027
(the “Notes”), including $25,000,000 principal amount of Notes purchased upon exercise of their
option to purchase such additional Notes. The Notes will be convertible, subject to the terms
thereof, into cash and fully paid, nonassessable shares of common stock, par value $0.001 per
share, if any, of the Company (the “Common Stock”), unless the Company elects to satisfy its entire
conversion obligation in shares of Common Stock. The Notes will be convertible on the terms, and
subject to the conditions, set forth in the Indenture (as defined herein). To induce the Initial
Purchasers to purchase the Notes, the Company has agreed to provide the registration rights set
forth in this Agreement pursuant to the Purchase Agreement.

The parties hereby agree as follows:

1. Definitions. Capitalized terms used in this Agreement without definition shall have their
respective meanings set forth in the Purchase Agreement. As used in this Agreement, the following
capitalized terms shall have the following meanings:

     “Additional Amounts”: As defined in Section 3(a) hereof.

     “Additional Amounts Payment Date”: Each June 30 and December 31.

     “Affiliate” of any specified person means any other person that, directly or indirectly, is in
control of, is controlled by, or is under common control with, such specified person. For purposes
of this definition, control of a person means the power, direct or indirect, to direct or cause the
direction of the management and policies of such person whether by contract or otherwise; and the
terms “controlling” and “controlled” have meanings correlative to the foregoing.

     “Agreement”: This Registration Rights Agreement.

     “Amendment Effectiveness Deadline Date” As defined in Section 2(f)(i) hereof.

     “Automatic Shelf Registration Statement”: An automatic shelf registration statement within the
meaning of Rule 405 under the Securities Act.

     “Blue Sky Application”: As defined in Section 6(a)(i) hereof.

     “Business Day”: The definition of “Business Day” in the Indenture.

 

 

     “Closing Date”: The date of the first issuance of the Notes.

     “Commission”: Securities and Exchange Commission.

     “Common Stock”: As defined in the preamble hereto.

     “Company”: As defined in the preamble hereto.

     “Effectiveness Period”: As defined in Section 2(a)(iii) hereof.

     “Effectiveness Target Date”: As defined in Section 2(a)(ii) hereof.

     “Exchange Act”: Securities Exchange Act of 1934, as amended.

     “Holder”: A Person who owns, beneficially or otherwise, Transfer Restricted Securities.

     “Indemnified Holder”: As defined in Section 6(a) hereof.

     “Indenture”: The Indenture, dated as of June 27, 2007 between the Company and U.S. Bank
National Association, as trustee (the “Trustee”), pursuant to which the Notes are to be issued, as
such Indenture is amended, modified or supplemented from time to time in accordance with the terms
thereof.

     “Initial Placement”: As defined in the preamble hereto.

     “Initial Purchasers”: As defined in the preamble hereto.

     “Losses”: As defined in Section 6(e) hereof.

     “Majority of Holders”: Holders holding over 50% of the aggregate principal amount of Notes
outstanding; provided that, for the purpose of this definition, a holder of shares of Common Stock
which constitute Transfer Restricted Securities and were issued upon conversion of the Notes shall
be deemed to hold an aggregate principal amount of the Notes (in addition to the principal amount
of the Notes held by such holder) equal to the quotient of (x) the number of such shares of Common
Stock held by such holder and (y) the conversion rate in effect at the time of such conversion as
determined in accordance with the Indenture.

     “Managing Underwriter”: The investment banker or investment bankers and manager or managers
that administer an underwritten offering, if any, conducted pursuant to Section 8 hereof.

     “NASD”: National Association of Securities Dealers, Inc.

     “Notes”: As defined in the preamble hereto.

     “Notice and Questionnaire”: A written notice executed by a Holder and delivered to the Company
containing substantially the information called for by the Form of Selling Securityholder Notice
and Questionnaire attached as Annex A to the Offering Memorandum of the Company relating to the
Notes.

2

 

     “Notice Holder”: On any date, any Holder of Transfer Restricted Securities that has delivered
a Notice and Questionnaire to the Company on or prior to such date.

     “Person”: An individual, partnership, corporation, company, unincorporated organization,
trust, joint venture or a government or agency or political subdivision thereof, or another entity.

     “Prospectus”: The prospectus included in a Shelf Registration Statement, as amended or
supplemented by any prospectus supplement and by all other amendments thereto, including
post-effective amendments, and all material incorporated by reference into such prospectus.

     “Purchase Agreement”: As defined in the preamble hereto.

     “Record Holder”: With respect to any Additional Amounts Payment Date, each Person who is a
Holder on the Interest Record Date (as defined in the Indenture) for the Notes immediately
preceding the relevant Additional Amounts Payment Date. In the case of a Holder of shares of
Common Stock issued upon conversion of the Notes, “Record Holder” shall mean each Person who is a
Holder of shares of Common Stock which constitute Transfer Restricted Securities on the Interest
Record Date.

     “Registration Default”: As defined in Section 3(a) hereof.

     “Representatives”: As defined in the preamble hereto.

     “Securities Act”: The Securities Act of 1933, as amended.

     “Shelf Filing Deadline”: As defined in Section 2(a)(i) hereof.

     “Shelf Registration Statement”: As defined in Section 2(a)(i) hereof.

     “Subsequent Shelf Registration Statement”: As defined in Section 2(c) hereof.

     “Suspension Notice”: As defined in Section 4(c) hereof.

     “Suspension Period”: As defined in Section 4(b)(ii) hereof.

     “TIA”: Trust Indenture Act of 1939, as amended, and the rules and regulations of the
Commission thereunder, in each case, as in effect on the date the Indenture is qualified under the
TIA.

     “Transfer Restricted Securities”: Each Note and each share of Common Stock issued upon
conversion of Notes until the earliest of:

     (i) the date on which such Note or such share of Common Stock issued upon conversion
has been effectively registered under the Securities Act and disposed of in accordance with
the Shelf Registration Statement or a Subsequent Shelf Registration Statement;

3

 

     (ii) the date on which such Note or such share of Common Stock issued upon conversion
is transferred in compliance with Rule 144 under the Securities Act or may be sold or
transferred by a Person who is not an Affiliate of the Company pursuant to Rule 144 under
the Securities Act (or any other similar provision then in force) without any volume or
manner of sale restrictions thereunder; or

     (iii) the date on which such Note or such share of Common Stock issued upon conversion
ceases to be outstanding (whether as a result of redemption, repurchase and cancellation,
conversion or otherwise).

          “Underwriter”: Any underwriter of Notes in connection with an offering thereof under the Shelf
Registration Statement.

          “WKSI”: A “well known seasoned issuer” as defined in Rule 405 under the Securities Act.

          “Underwritten Registration”: A registration in which Notes of the Company are sold to an
underwriter for reoffering to the public.

Unless the context otherwise requires, the singular includes the plural, and words in the plural
include the singular.

2. Shelf Registration.

     (a) The Company shall:

     (i) as promptly as practicable (but in no event more than 120 days after the Closing
Date) (the “Shelf Filing Deadline”), cause to be filed a registration statement pursuant to
Rule 415 under the Securities Act or any similar rule that may be adopted by the Commission
(the “Shelf Registration Statement”), which Shelf Registration Statement shall be an
Automatic Shelf Registration Statement if the Company is then a WKSI and shall provide for
the registration and resales, on a continuous or delayed basis, of all Transfer Restricted
Securities held by Holders that have provided the information required pursuant to the terms
of Section 2(b) hereof;

     (ii) if the Company is not a WKSI when the shelf registration statement is filed and
therefore did not file an Automatic Shelf Registration Statement, use its reasonable efforts
to cause the Shelf Registration Statement to be declared effective under the Securities Act
by the Commission not later than 210 days after the date hereof (the “Effectiveness Target
Date”); and

     (iii) use its reasonable efforts to keep the Shelf Registration Statement continuously
effective, supplemented and amended as required by the Securities Act and
by the provisions of Section 4(b) hereof to the extent necessary to ensure that it (A)
is available for resales by the Holders of Transfer Restricted Securities entitled, subject
to Section 2(b), to the benefit of this Agreement and (B) conforms with the requirements of
this Agreement and the Securities Act and the rules and regulations of the Commission
promulgated thereunder as announced from time to time, for a period (the “Effectiveness

4

 

Period”) from the date the Shelf Registration Statement becomes or is declared effective by
the Commission until the earlier of:

     (1) the date when the Holders of Transfer Restricted Securities are able to
sell all such Transfer Restricted Securities immediately without restriction
pursuant to Rule 144(k) under the Securities Act; or

     (2) the date when (a) all of the Transfer Restricted Securities of those
Holders that complete and deliver in a timely manner the Notice and Questionnaire
described below are registered under the Shelf Registration Statement and disposed
of in accordance with the Shelf Registration Statement or pursuant to Rule 144(k)
under the Securities Act or any similar rule that may be adopted by the Commission
or (b) the Transfer Restricted Securities cease to be outstanding.

The Company shall be deemed not to have used its reasonable efforts to keep the Shelf Registration
Statement effective during the Effectiveness Period if it voluntarily takes any action that would
result in Holders of Transfer Restricted Securities not being able to offer and sell such
Securities at any time during the Effectiveness Period, unless such action is (x) required by
applicable law or otherwise undertaken by the Company in good faith and for valid business reasons
(not including avoidance of the Company’s obligations hereunder), including the acquisition or
divestiture of assets, and (y) permitted by Section 4(b)(ii) hereof.

     (b) At the time the Shelf Registration Statement becomes or is declared effective, each Holder
that became a Notice Holder on or prior to the date ten (10) Business Days prior to such time of
effectiveness shall be named as a selling securityholder in the Shelf Registration Statement and
the related Prospectus in such a manner as to permit such Holder to deliver such Prospectus to
purchasers of Transfer Restricted Securities in accordance with applicable law. None of the
Company’s security holders (other than the Holders of Transfer Restricted Securities) shall have
the right to include any of the Company’s securities in the Shelf Registration Statement.

     (c) If the Shelf Registration Statement or any Subsequent Shelf Registration Statement ceases
to be effective for any reason at any time during the Effectiveness Period (other than because all
Transfer Restricted Securities registered thereunder shall have been resold pursuant thereto or
shall have otherwise ceased to be Transfer Restricted Securities), the Company shall use its
reasonable best efforts to obtain the prompt withdrawal of any order suspending the effectiveness
thereof or file an additional Shelf Registration Statement (which shall be an Automatic Shelf
Registration Statement if the Company is then a WKSI) covering all of the securities that as of the
date of such filing are Transfer Restricted Securities (a “Subsequent Shelf Registration
Statement”). If a Subsequent Shelf Registration Statement is filed and is not an Automatic Shelf
Registration Statement, the Company shall use its reasonable
best efforts to cause the Subsequent Shelf Registration Statement to become effective as
promptly as is practicable after such filing and to keep such Shelf Registration Statement (or
Subsequent Shelf Registration Statement) continuously effective until the end of the Effectiveness
Period.

5

 

     (d) The Company shall supplement and amend the Shelf Registration Statement if required by the
rules, regulations or instructions applicable to the registration form used by the Company for such
Shelf Registration Statement, if required by the Securities Act.

     (e) The Company shall cause the Shelf Registration Statement and the related Prospectus and
any amendment or supplement thereto, as of the effective date of the Shelf Registration Statement
or such amendment or supplement, (i) to comply in all material respects with the applicable
requirements of the Securities Act, and (ii) not to contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein (in the case of the Prospectus, in light of the circumstances under which they
were made) not misleading.

     (f) Each Holder agrees that if such Holder wishes to sell Transfer Restricted Securities
pursuant to a Shelf Registration Statement and related Prospectus, it will do so only in accordance
with this Section 2(f) and Section 4(b). Each Holder wishing to sell Transfer Restricted
Securities pursuant to a Shelf Registration Statement and related Prospectus agrees to deliver a
Notice and Questionnaire to the Company at least ten (10) Business Days prior to any intended
distribution of Transfer Restricted Securities under the Shelf Registration Statement. From and
after the date the Shelf Registration Statement becomes or is declared effective, the Company
shall, as promptly as practicable after the date a Notice and Questionnaire is delivered to it:

     (i) if required by applicable law, file with the Commission a post-effective amendment
to the Shelf Registration Statement or prepare and, if required by applicable law, file a
supplement to the related Prospectus or a supplement or amendment to any document
incorporated therein by reference or file any other required document so that the Holder
delivering such Notice and Questionnaire is named as a selling securityholder in the Shelf
Registration Statement and the related Prospectus in such a manner as to permit such Holder
to deliver such Prospectus to purchasers of the Transfer Restricted Securities in accordance
with applicable law and, if the Company shall file a post-effective amendment to the Shelf
Registration Statement and if such Shelf Registration Statement is not an Automatic Shelf
Registration Statement, use its reasonable best efforts to cause such post-effective
amendment to be declared effective under the Securities Act as promptly as is practicable,
but in any event by the date (the “Amendment Effectiveness Deadline Date”) that is
forty-five (45) days after the date such post effective amendment is required by this clause
to be filed;

     (ii) provide such Holder copies of any documents filed pursuant to Section 2(f)(i); and

     (iii) notify such Holder as promptly as practicable after the effectiveness under the
Securities Act of any post-effective amendment filed pursuant to Section 2(f)(i);

provided that if such Notice and Questionnaire is delivered during a Suspension Period, the
Company
shall so inform the Holder delivering such Notice and Questionnaire and shall take the actions set
forth in clauses (i), (ii) and (iii) above upon expiration of the Suspension Period in accordance
with Section 4(b). Notwithstanding anything contained herein to the contrary, (i) the

6

 

Company
shall be under no obligation to name any Holder that is not a Notice Holder as a selling
securityholder in any Registration Statement or related Prospectus and (ii) the Amendment
Effectiveness Deadline Date shall be extended by up to fifteen (15) Business Days from the
Expiration of a Suspension Period (and the Company shall incur no obligation to pay Additional
Amounts during such extension) if such Suspension Period shall be in effect on the Amendment
Effectiveness Deadline Date.

3. Additional Amounts.

     (a) If:

     (i) the Shelf Registration Statement is not filed with the Commission and, if the
Company is then a WKSI, does not become automatically effective prior to or on the Shelf
Filing Deadline;

     (ii) the Company is not a WKSI on the Shelf Filing Deadline, and the Shelf Registration
Statement has not been declared effective by the Commission prior to or on the Effectiveness
Target Date;

     (iii) the Company has failed to perform its obligations set forth in Section 2(f)
within the time period required therein;

     (iv) any post-effective amendment to a Shelf Registration filed pursuant to Section
2(f)(i) has not become effective under the Securities Act on or prior to the Amendment
Effectiveness Deadline Date;

     (v) except as provided in Section 4(b)(i) hereof, the Shelf Registration Statement
becomes or is declared effective but, during the Effectiveness Period, shall thereafter
cease to be effective or fail to be usable for its intended purpose without being succeeded
within ten (10) Business Days by a post-effective amendment to the Shelf Registration
Statement, a supplement to the Prospectus or a report filed with the Commission pursuant to
Section 13(a), 13(c), 14 or 15(d) of the Exchange Act that cures such failure and, in the
case of a post-effective amendment, is itself immediately declared effective; or

     (vi) Suspension Periods exceed an aggregate of 45 or 60 days, as the case may be,
within any 90-day period or an aggregate of 120 days in any 360-day period;

each such event referred to in foregoing clauses (i) through (vi), a “Registration
Default”), the Company hereby agrees to pay interest (“Additional Amounts”) with respect to
Notes that are Transfer Restricted Securities from and including the day following the
Registration Default to but excluding the earlier of (1) the day on which the Registration
Default has been cured and (2) the date the Shelf Registration Statement is no longer
required to be kept effective, accruing at a rate:

     (A) in respect of the Notes that are Transfer Restricted Securities to each
Holder of such Notes, (x) with respect to the first 90-day period during which a
Registration Default shall have occurred and be continuing, equal to

7

 

0.25% per annum
of the aggregate principal amount of the Notes, and (y) with respect to the period
commencing on the 91st day following the day the Registration Default shall have
occurred and be continuing, equal to 0.50% per annum of the aggregate principal
amount of the Notes; provided that in no event shall Additional Amounts accrue at a
rate per year exceeding 0.50% of the aggregate principal amount of the Notes; and

     (B) in respect of the Notes that are Transfer Restricted Securities submitted
for conversion into Common Stock during the existence of a Registration Default with
respect to the Common Stock, the Holder will not be entitled to receive any
Additional Amounts with respect to such Common Stock but will receive from the
Company on the settlement date with respect to such conversion, accrued and unpaid
Additional Amounts to the Holders of such Notes calculated in accordance with
paragraph (A) to the Conversion Date (as defined in the Indenture) relating to such
settlement date; and

     (C) a Holder of Common Stock, if any, issued upon conversion of the Notes will
not be entitled to any Additional Amounts if the Registration Default with respect
to such Common Stock occurs after such Holder has converted the Notes into Common
Stock.

     (b) All accrued Additional Amounts, except for Additional Amounts paid under the circumstances
set forth in paragraph (B) of Section 3(a) above, shall be paid in arrears to Record Holders by the
Company on each Additional Amounts Payment Date. Upon the cure of all Registration Defaults
relating to any particular Note, the accrual of Additional Amounts with respect to such Note will
cease.

All obligations of the Company set forth in this Section 3 that are outstanding with respect to any
Note that is a Transfer Restricted Security at the time such security ceases to be a Transfer
Restricted Security shall survive until such time as all such obligations with respect to such
Transfer Restricted Security shall have been satisfied in full.

The Additional Amounts set forth above shall be the exclusive monetary remedy available to the
Holders of Notes that are Transfer Restricted Securities for each Registration Default.

4. Registration Procedures.

     (a) In connection with the Shelf Registration Statement, the Company shall comply with all the
provisions of Section 4(b) hereof and shall use its reasonable best efforts to effect such
registration to permit the sale of the Transfer Restricted Securities, and pursuant thereto, shall
as promptly as practicable prepare and file with the Commission a Shelf Registration Statement
relating to the registration on any appropriate form under the Securities Act.

     (b) In connection with the Shelf Registration Statement and any Prospectus required by this
Agreement to permit the sale or resale of Transfer Restricted Securities, the Company shall:

8

 

     (i) subject to any notice by the Company in accordance with this Section 4(b) of the
existence of any fact or event of the kind described in Section 4(b)(iv)(D), use its
reasonable efforts to keep the Shelf Registration Statement continuously effective during
the Effectiveness Period; upon the occurrence of any event that would cause the Shelf
Registration Statement or the Prospectus contained therein (A) to contain a material
misstatement or omission or (B) not to be effective and usable for resale of Transfer
Restricted Securities during the Effectiveness Period, the Company shall file promptly an
appropriate amendment to the Shelf Registration Statement, a supplement to the Prospectus or
a report filed with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act, in the case of clause (A), correcting any such misstatement or omission, and,
in the case of either clause (A) or (B), if such amendment does not become automatically
effective upon filing with the Commission, use its reasonable best efforts to cause such
amendment to be declared effective and the Shelf Registration Statement and the related
Prospectus to become usable for their intended purposes as soon as practicable thereafter.

     (ii) notwithstanding Section 4(b)(i) hereof, the Company may suspend the effectiveness
of the Shelf Registration Statement (each such period, a “Suspension Period”):

     (x) if an event occurs and is continuing as a result of which the Shelf
Registration Statement, the Prospectus, any amendment or supplement thereto, or any
document incorporated by reference therein would, in the Company’s judgment, contain
an untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading; and

     (y) if the Company determines in good faith that the disclosure of a material
event at such time would be seriously detrimental to the Company and its
subsidiaries.

Upon the occurrence of any event described in clauses (x) and (y) of this Section 4(b)(ii), the
Company shall give notice to the Holders that the availability of the Shelf Registration is
suspended and, upon actual receipt of any such notice, each Holder agrees not to sell any Transfer
Restricted Securities pursuant to the Shelf Registration until such Holder’s receipt of copies of
the supplemented or amended Prospectus provided for in Section 4(b) hereof. The period during
which the availability of the Shelf Registration and any Prospectus is suspended (the “Suspension
Period”) shall not exceed 45 days in any 90-day period, provided that, in the event the disclosure
relates to a previously undisclosed proposed or pending material business transaction, the
disclosure of which the Company determines in good faith would be reasonably likely to impede the
Company’s ability to consummate such transaction, the Company may extend a Suspension Period from
45 days to 60 days; provided, further, that Suspension Periods shall not exceed an aggregate of 120
days in any 360-day period. The Company shall not be
required to specify in the written notice to the Holders the nature of the event giving rise to the
Suspension Period.

9

 

     (iii) prepare and file with the Commission such amendments and post-effective
amendments to the Shelf Registration Statement as may be necessary to keep the Shelf
Registration Statement effective during the Effectiveness Period; cause the Prospectus to be
supplemented by any required Prospectus supplement, and as so supplemented to be filed
pursuant to Rule 424 under the Securities Act, and to comply fully with the applicable
provisions of Rules 424 under the Securities Act in a timely manner; and comply with the
provisions of the Securities Act with respect to the disposition of all Transfer Restricted
Securities covered by the Shelf Registration Statement during the applicable period in
accordance with the intended method or methods of distribution by the sellers thereof set
forth in the Shelf Registration Statement or supplement to the Prospectus.

     (iv) advise the selling Holders and any Initial Purchaser that has provided in writing
to the Company a telephone or facsimile number and address for notices, promptly and, if
requested by such selling Holders or Initial Purchaser, to confirm such advice in writing
(which notice pursuant to clauses (B) through (D) below shall be accompanied by an
instruction to suspend the use of the Prospectus until the Company shall have remedied the
basis for such suspension):

     (A) when the Prospectus or any Prospectus supplement or post-effective
amendment has been filed, and, with respect to the Shelf Registration Statement or
any post-effective amendment thereto, when the same has become effective,

     (B) of any request by the Commission for amendments to the Shelf Registration
Statement or amendments or supplements to the Prospectus or for additional
information relating thereto; provided, however, that notice of any such request
provided to the Depository Trust Company and the Trustee shall be deemed to be
provided to all of the Notice Holders and the Initial Purchasers,

     (C) of the issuance by the Commission of any stop order suspending the
effectiveness of the Shelf Registration Statement under the Securities Act or of the
suspension by any state securities commission of the qualification of the Transfer
Restricted Securities for offering or sale in any jurisdiction, or the threatening
or initiation of any proceeding for any of the preceding purposes, or

     (D) of the happening of any event or the failure of any event to occur or the
discovery of any facts, during the Effectiveness Period, which makes any statement
made in a Shelf Registration Statement, the related Prospectus, any amendment or
supplement thereto or any document incorporated by reference therein untrue in any
material respect or which causes such document(s) to omit to state a material fact
necessary in order to make the statements therein (in the case of the Prospectus, in
the light of the circumstances under which they were made) not misleading.

     (v) if at any time the Commission shall issue any stop order suspending the
effectiveness of the Shelf Registration Statement, or any state securities commission or

10

 

other regulatory authority shall issue an order suspending the qualification or exemption
from qualification of the Transfer Restricted Securities under state securities or Blue Sky
laws, use its reasonable best efforts to obtain the withdrawal or lifting of such order at
the earliest possible time and shall provide to each Holder who is named in the Shelf
Registration Statement prompt notice of the withdrawal of any such order.

     (vi) make available at reasonable times for inspection by one or more representatives
of the selling Holders, designated in writing by a Majority of Holders whose Transfer
Restricted Securities are included in the Shelf Registration Statement, and any attorney or
accountant retained by such selling Holders and any Initial Purchaser participating in any
disposition pursuant to the Shelf Registration Statement, all financial and other records,
pertinent corporate documents and properties of the Company as shall be reasonably necessary
to enable them to conduct a reasonable investigation within the meaning of Section 11 of the
Securities Act, and cause the Company’s officers, directors, managers and employees to
supply all information reasonably requested by any such representative or representatives of
the selling Holders, attorney or accountant in connection therewith; provided that, subject
to Section 4(b)(i), (x) appropriate safeguards are in place to protect the confidentiality
of such information and (y) in no event shall the Company be required to disclose any
proprietary information to any competitor or agent thereof.

     (vii) if requested by any selling Holders or the Representatives, promptly incorporate
into the Shelf Registration Statement or Prospectus, pursuant to a supplement or
post-effective amendment if necessary, such information as such selling Holders may
reasonably request to have included therein, including, without limitation, information
relating to the “Plan of Distribution” of the Transfer Restricted Securities.

     (viii) deliver to each selling Holder, without charge, as many copies of the Prospectus
(including each preliminary Prospectus) and any amendment or supplement thereto as such
Persons reasonably may request; subject to any notice by the Company in accordance with this
Section 4(b) of the existence of any fact or event of the kind described in Section
4(b)(iii)(D), the Company hereby consents to the use of the Prospectus and any amendment or
supplement thereto by each of the selling Holders in connection with the offering and the
sale of the Transfer Restricted Securities covered by the Prospectus or any amendment or
supplement thereto.

     (ix) before any public offering of Transfer Restricted Securities, cooperate with the
selling Holders and their counsel in connection with the registration and qualification of
the Transfer Restricted Securities under the securities or Blue Sky laws of such
jurisdictions in the United States as the selling Holders may reasonably request and do any
and all other acts or things necessary or advisable to enable the disposition in such
jurisdictions of the Transfer Restricted Securities covered by the Shelf Registration
Statement; provided, however, that the Company shall not be required (A) to register or
qualify as a foreign corporation or a dealer of securities in any jurisdiction where it
would not otherwise be required to qualify but for this Section 4(b)(ix) or to take any
action that
would subject it to the service of process in any jurisdiction where it would not
otherwise

11

 

be subject to such service of process or (B) to subject itself to general or
unlimited service of process or to taxation in any such jurisdiction if it is not then so
subject.

     (x) unless any Transfer Restricted Securities shall be in book-entry form only,
cooperate with the selling Holders to facilitate the timely preparation and delivery of
certificates representing Transfer Restricted Securities to be sold and not bearing any
restrictive legends (unless required by applicable securities laws); and enable such
Transfer Restricted Securities to be in such denominations and registered in such names as
the Holders may request at least two Business Days before any sale of Transfer Restricted
Securities.

     (xi) use its reasonable best efforts to cause the Transfer Restricted Securities
covered by the Shelf Registration Statement to be registered with or approved by such other
U.S. governmental agencies or authorities as may be necessary to enable the seller or
sellers thereof to consummate the disposition of such Transfer Restricted Securities.

     (xii) subject to Section 4(b)(ii) hereof, if any fact or event contemplated by Section
4(b)(iv)(B) through (D) hereof shall exist or have occurred, use its reasonable best efforts
to prepare a supplement or post-effective amendment to the Shelf Registration Statement or
related Prospectus or any document incorporated therein by reference or file any other
required document so that, as thereafter delivered to the purchasers of Transfer Restricted
Securities, the Prospectus will not contain an untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances in which they are made, not misleading.

     (xiii) provide CUSIP numbers for all Transfer Restricted Securities not later than the
effective date of the Shelf Registration Statement and provide the Trustee under the
Indenture with certificates for the Notes that are in a form eligible for deposit with The
Depository Trust Company.

     (xiv) cooperate and assist in any filings required to be made with the NASD and in the
performance of any due diligence investigation by any underwriter that is required to be
undertaken in accordance with the rules and regulations of the NASD.

     (xv) otherwise use its reasonable best efforts to comply with all applicable rules and
regulations of the Commission and all reporting requirements under the rules and regulations
of the Exchange Act.

     (xvi) make generally available to its security holders an earnings statement satisfying
the provisions of Section 11(a) of the Securities Act and Rule 158 of the Securities Act as
soon as practicable after the effective date of the Shelf Registration Statement and in any
event no later than 45 days after the end of a 12-month period (or 90 days, if such period
is a fiscal year) beginning with the first month of the Company’s first fiscal quarter
commencing after the effective date of the Shelf Registration Statement.

12

 

     (xvii) cause the Indenture to be qualified under the TIA not later than the effective
date of the Shelf Registration Statement required by this Agreement, and, in connection
therewith, cooperate with the Trustee and the holders of Notes to effect such changes to the
Indenture as may be required for such Indenture to be so qualified in accordance with the
terms of the TIA; and execute and use its reasonable best efforts to cause the Trustee
thereunder to execute all documents that may be required to effect such changes and all
other forms and documents required to be filed with the Commission to enable such Indenture
to be so qualified in a timely manner. In the event that any such amendment or modification
referred to in this Section 4(b)(xvii) involves the appointment of a new trustee under the
Indenture, the Company shall appoint a new trustee thereunder pursuant to the applicable
provisions of the Indenture.

     (xviii) cause all Common Stock covered by the Shelf Registration Statement to be listed
or quoted, as the case may be, on each securities exchange or automated quotation system on
which Common Stock is then listed or quoted.

     (xix) provide to each Holder upon written request each document filed with the
Commission pursuant to the requirements of Section 13 and Section 15 of the Exchange Act
after the effective date of the Shelf Registration Statement, unless such document is
available through the Commission’s EDGAR system.

     (xx) use its reasonable best efforts if the Notes have been rated prior to the initial
sale of such Notes, to confirm such ratings will apply to the Notes covered by the Shelf
Registration Statement.

     (xxi) in connection with any underwritten offering conducted pursuant to Section 8
hereof, make such representations and warranties to the Holders of Securities registered
thereunder and the underwriters, in form, substance and scope as are customarily made by
issuers to underwriters in primary underwritten offerings and covering matters including,
but not limited to, those set forth in the Purchase Agreement;

     (xxii) in connection with any underwritten offering conducted pursuant to Section 8
hereof, obtain opinions of counsel to the Company and updates thereof (which counsel and
opinions (in form, scope and substance) shall be reasonably satisfactory to the Managing
Underwriters) addressed to each selling Holder and the underwriters, if any, covering such
matters as are customarily covered in opinions requested in underwritten offerings and such
other matters as may be reasonably requested by such Holders and underwriters;

     (xxiii) in connection with any underwritten offering conducted pursuant to Section 8,
hereof, obtain “comfort” letters and updates thereof from the independent certified public
accountants of the Company (and, if necessary, any other independent certified public
accountants of any subsidiary of the Company or of any business acquired by the Company for
which financial statements and financial data are, or are required to be, included in the
Shelf Registration Statement), addressed to each selling Holder of Securities registered
thereunder and the underwriters, in customary form and

13

 

covering matters of the type customarily covered in “comfort” letters in connection
with primary underwritten offerings;

     (xxiv) in connection with any underwritten offering conducted pursuant to Section 8
hereof, deliver such documents and certificates as may be reasonably requested by the
Majority of Holders and the Managing Underwriters, including those to evidence compliance
with Section 4(b)(ii) and 4(b)(xii) hereof and with any customary conditions contained in
the Purchase Agreement or other agreement entered into by the Company;

     (xxv) in connection with underwritten offering conducted pursuant to Section 8 hereof,
the Company shall, if requested, promptly include or incorporate in a Prospectus supplement
or post-effective amendment to the Shelf Registration Statement such information as the
Managing Underwriters reasonably agree should be included therein and to which the Company
does not reasonably object and shall make all required filings of such Prospectus supplement
or post-effective amendment as soon as practicable after it is notified of the matters to be
included or incorporated in such Prospectus supplement or post-effective amendment;

     (xxvi) use its reasonable best efforts to take all other steps necessary to effect the
registration of the Notes covered by the Shelf Registration Statement; and

     (xxvii) enter into customary agreements (including, if requested, an underwriting
agreement in customary form) and take all other appropriate actions in order to expedite or
facilitate the registration or the disposition of the Notes, and in connection therewith, if
an underwriting agreement is entered into, cause the same to contain indemnification
provisions and procedures no less favorable than those set forth in Section 6 hereof.

The actions set forth in clauses (xxi), (xxii), (xxiii) and (xxiv) of this Section 4(b) shall be
performed at (a) the effectiveness of the Shelf Registration Statement and each post-effective
amendment thereto; and (b) each closing under any underwriting or similar agreement as and to the
extent required thereunder.

     (c) Each Holder agrees by acquisition of a Transfer Restricted Security that, upon receipt of
any notice (a “Suspension Notice”) from the Company under Section 4(b)(ii) or the existence of any
fact of the kind described in Section 4(b)(iv)(D) hereof, such Holder will forthwith discontinue
disposition of Transfer Restricted Securities pursuant to the Shelf Registration Statement until:

     (i) such Holder has received copies of the supplemented or amended Prospectus
contemplated by Section 4(b)(xii) hereof; or

     (ii) such Holder is advised in writing by the Company that the use of the Prospectus
may be resumed, and has received copies of any additional or supplemental filings that are
incorporated by reference in the Prospectus; provided, however, that any such document filed
and publicly available through the Commission’s EDGAR system shall be deemed to have been
received by such Holder.

14

 

If so directed by the Company, each Holder will deliver to the Company (at the Company’s expense)
all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus
covering such Transfer Restricted Securities that was current at the time of receipt of such notice
of suspension.

     (d) Each Holder agrees by acquisition of a Transfer Restricted Security, that no Holder shall
be entitled to sell any of such Transfer Restricted Securities pursuant to a Shelf Registration
Statement; or to receive a Prospectus relating thereto, unless such Holder has furnished the
Company with a Notice and Questionnaire as required pursuant to Section 2(e) hereof (including the
information required to be included in such Notice and Questionnaire) and the information set forth
in the following two sentences. The Company may require each Notice Holder of Transfer Restricted
Securities to be sold pursuant to the Shelf Registration Statement to furnish to the Company such
information regarding the Holder and the distribution of such Transfer Restricted Securities as the
Company may from time to time reasonably require for inclusion in such Registration Statement.
Each Notice Holder agrees promptly to furnish to the Company all information required to be
disclosed in order to make the information previously furnished to the Company by such Notice
Holder not misleading and any other information regarding such Notice Holder and the distribution
of such Transfer Restricted Securities as the Company may from time to time reasonably request in
writing. Any sale of any Transfer Restricted Securities by any Holder shall constitute a
representation and warranty by such Holder that the information relating to such Holder and its
plan of distribution is as set forth in the Prospectus delivered by such Holder in connection with
such disposition, that such Prospectus does not as of the time of such sale contain any untrue
statement of a material fact relating to or provided by such Holder or its plan of distribution and
that such Prospectus does not as of the time of such sale omit to state any material fact relating
to or provided by such Holder or its plan of distribution necessary to make the statements in such
Prospectus, in the light of the circumstances under which they were made not misleading. The
Company may exclude from such Shelf Registration Statement the Notes of any Holder that
unreasonably fails to furnish such information within a reasonable time after receiving such
request.

5. Registration Expenses.

All expenses incident to the Company’s performance of or compliance with this Agreement shall be
borne by the Company regardless of whether a Shelf Registration Statement becomes effective,
including, without limitation:

     (a) all registration and filing fees and expenses (including filings made with the
NASD);

     (b) all fees and expenses of compliance with federal securities and state Blue Sky or
securities laws;

     (c) all expenses of printing (including printing of Prospectuses and certificates for
any Common Stock to be issued upon conversion of the Notes) and the Company’s expenses for
messenger and delivery services and telephone;

     (d) all fees and disbursements of counsel to the Company;

15

 

     (e) all application and filing fees in connection with listing (or authorizing for
quotation) the Common Stock on a national securities exchange or automated quotation system
pursuant to the requirements hereof; and

     (f) all fees and disbursements of independent certified public accountants of the
Company.

The Company shall bear its internal expenses (including, without limitation, all salaries and
expenses of its officers and employees performing legal, accounting or other duties), the expenses
of any annual audit and the fees and expenses of any Person, including special experts, retained by
the Company. The Company shall pay all expenses customarily borne by issuers in an underwritten
offering to the extent set forth in Section 8(c) hereof.

6. Indemnification And Contribution.

     (a) The Company agrees to indemnify and hold harmless each Holder of Transfer Restricted
Securities (including each Initial Purchaser in its capacity as such), its directors, officers, and
employees, Affiliates and agents and each Person, if any, who controls any such Holder within the
meaning of the Securities Act or the Exchange Act (each, an “Indemnified Holder”), against any
loss, claim, damage, liability or expense, joint or several, or any action in respect thereof
(including, but not limited to, any loss, claim, damage, liability or action relating to resales of
the Transfer Restricted Securities), to which such Indemnified Holder may become subject, insofar
as any such loss, claim, damage, liability or action arises out of, or is based upon:

     (i) any untrue statement or alleged untrue statement of a material fact contained in
(A) the Shelf Registration Statement at the time that it becomes or is declared effective or
in any amendment thereof, in any Prospectus, or in any amendment or supplement thereto or
any issuer free writing prospectus in respect thereof, or (B) any Blue Sky application or
other document or any amendment or supplement thereto prepared or executed by the Company
(or based upon written information furnished by or on behalf of the Company expressly for
use in such Blue Sky application or other document or amendment or supplement) filed in any
jurisdiction specifically for the purpose of qualifying any or all of the Transfer
Restricted Securities under the securities law of any state or other jurisdiction (such
application or document being hereinafter called a “Blue Sky Application”); or

     (ii) the omission or alleged omission to state therein any material fact required to be
stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, and agrees to reimburse each
Indemnified Holder promptly upon demand for any legal or other expenses reasonably incurred
by such Indemnified Holder in connection with investigating, defending, settling,
compromising or paying any such loss, claim, damage, liability, expense or action; provided,
however, that the Company shall not be liable in any such case to the extent that any such
loss, claim, damage, liability or expense arises out of, or is based upon, any untrue
statement or alleged untrue statement or omission or alleged omission made in reliance upon
and in conformity with written information furnished to the Company by or on behalf of such
Holder (or its related Indemnified Holder) specifically

16

 

for use therein. The foregoing indemnity agreement is in addition to any liability
which the Company may otherwise have.

The Company also agrees to indemnify as provided in this Section 6(a) or contribute as provided in
Section 6(e) hereof to Losses (as defined below) of each underwriter, if any, of Notes registered
under a Shelf Registration Statement, their directors, officers, employees, Affiliates or agents
and each Person who controls such underwriter on substantially the same basis as that of the
indemnification of the Initial Purchasers and the selling Holders provided in this Section 6(a) and
shall, if requested by any Holder, enter into an underwriting agreement reflecting such agreement,
as provided in Section 4(b)(xxvi) hereof.

     (b) Each Holder, severally and not jointly, agrees to indemnify and hold harmless the Company,
its directors, officers, employees and agents and each Person, if any, who controls the Company
within the meaning of the Securities Act or the Exchange Act to the same extent as the foregoing
indemnity from the Company to each such Holder, but only with reference to written information
relating to such Holder furnished to the Company by or on behalf of such Holder specifically for
inclusion in the documents referred to in the foregoing indemnity; provided, however, that no such
Holder shall be liable for any indemnity claims hereunder in excess of the amount of net proceeds
received by such Holder from the sale of Transfer Restricted Securities pursuant to such
document(s). This indemnity agreement set forth in this Section shall be in addition to any
liabilities which any such Holder may otherwise have.

     (c) Promptly after receipt by an indemnified party under this Section 6 of notice of any claim
or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to
be made against the indemnifying party under this Section 6, notify the indemnifying party in
writing of the claim or the commencement of that action; provided, however, that the failure to
notify the indemnifying party (i) shall not relieve it from any liability which it may have under
paragraphs (a) or (b) of this Section unless and to the extent it did not otherwise learn of such
action and has been materially prejudiced (through the forfeiture of substantive rights and
defenses) by such failure and (ii) shall not, in any event, relieve it from any liability which it
may have to an indemnified party otherwise than under paragraphs (a) or (b) of this Section 6. If
any such claim or action shall be brought against an indemnified party, and it shall notify the
indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to
the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume
the defense thereof with counsel reasonably satisfactory to the indemnified party. After notice
from the indemnifying party to the indemnified party of its election to assume the defense of such
claim or action, the indemnifying party shall not be liable to the indemnified party under this
Section 6 for any legal or other expenses subsequently incurred by the indemnified party in
connection with the defense thereof other than reasonable costs of investigation; provided,
however, that the Holders shall have the right to employ a single counsel to represent jointly the
Holders and their officers, employees and controlling Persons who may be subject to liability
arising out of any claim in respect of which indemnity may be sought by the Holders against the
Company under this Section 6 if the Holders seeking indemnification shall have been advised by
legal counsel that there may be one or more legal defenses available to such Holders and their
respective officers, employees and controlling Persons that are different from or additional to
those available to the Company, and in that event, the reasonable fees and expenses of such
separate counsel shall be paid by the Company.

17

 

     (d) The indemnifying party under this Section shall not be liable for any settlement of any
proceeding effected without its written consent, which shall not be withheld unreasonably, but if
settled with such consent or if there is a final judgment for the plaintiff, the indemnifying party
agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense by
reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an
indemnified party shall have requested an indemnifying party to reimburse the indemnified party for
fees and expenses of counsel as contemplated by Section 6(c) hereof, the indemnifying party agrees
that it shall be liable for any settlement of any proceeding effected without its written consent
if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party
of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of
such settlement at least 30 days prior to such settlement being entered into, and (iii) such
indemnifying party shall not have reimbursed the indemnified party in accordance with such request
prior to the date of such settlement. Notwithstanding the immediately preceding sentence, if at any
time an indemnified party shall have requested an indemnifying party to reimburse the indemnified
party for fees and expenses of counsel, an indemnifying party shall not be liable for any
settlement effected without its consent if such indemnifying party (i) reimburses such indemnified
party in accordance with such request to the extent it considers such request to be reasonable and
(ii) provides written notice to the indemnified party substantiating the unpaid balance as
unreasonable, in each case prior to the date of such settlement. No indemnifying party shall,
without the prior written consent of the indemnified party, effect any settlement, compromise or
consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect
of which any indemnified party is or could have been a party and indemnity was or could have been
sought hereunder by such indemnified party, unless such settlement, compromise or consent (x)
includes an unconditional release of such indemnified party from all liability on claims that are
the subject matter of such action, suit or proceeding and (y) does not include a statement as to or
an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.

     (e) If the indemnification provided for in this Section 6 shall for any reason be unavailable
or insufficient to hold harmless an indemnified party under Section 6(a) or 6(b) in respect of any
loss, claim, damage or liability (or action in respect thereof) referred to therein, each
indemnifying party shall, in lieu of indemnifying such indemnified party, contribute to the
aggregate amount paid or payable by such indemnified party as a result of such loss, claim, damage
or liability (including legal or other expenses reasonably incurred in connection with
investigating or defending any loss, claim, liability, damage or action) (collectively “Losses”)
(or action in respect thereof):

     (i) in such proportion as is appropriate to reflect the relative benefits received by
the Company from the offering and sale of the Transfer Restricted Securities on the one hand
and a Holder with respect to the sale by such Holder of the Transfer Restricted Securities
on the other, or

     (ii) if the allocation provided by Section (6)(e)(i) is not permitted by applicable
law, in such proportion as is appropriate to reflect not only the relative benefits referred
to in Section 6(e)(i) but also the relative fault of the Company on the one hand and the
Holders on the other in connection with the statements or omissions or alleged

18

 

statements or alleged omissions that resulted in such loss, claim, damage or liability
(or action in respect thereof), as well as any other relevant equitable considerations.

The relative benefits received by the Company on the one hand and a Holder on the other with
respect to such offering and such sale shall be deemed to be in the same proportion as the total
net proceeds from the offering of the Notes purchased under the Purchase Agreement (before
deducting expenses) received by the Company, on the one hand, bear to the total proceeds received
by such Holder with respect to its sale of Transfer Restricted Securities on the other. The
relative fault of the parties shall be determined by reference to whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company on the one hand or the Holders on the other, the
intent of the parties and their relative knowledge, access to information and opportunity to
correct or prevent such statement or omission. The Company and each Holder agree that it would not
be just and equitable if the amount of contribution pursuant to this Section 6(e) were determined
by pro rata allocation or by any other method of allocation that does not take into account the
equitable considerations referred to in the first sentence of this paragraph (e).

The amount paid or payable by an indemnified party as a result of the loss, claim, damage or
liability, or action in respect thereof, referred to above in this Section 6 shall be deemed to
include, for purposes of this Section 6, any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending or preparing to defend any such
action or claim.

No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation. The Holders’ obligations to contribute as provided in this Section
6(e) are several and not joint.

     (f) The provisions of this Section 6 shall remain in full force and effect, regardless of any
investigation made by or on behalf of any Holder or the Company or any of the officers, directors
or controlling Persons referred to in Section 6 hereof, and will survive the sale by a Holder of
Transfer Restricted Securities.

7. Rule 144A and Rule 144. The Company agrees with each Holder, for so long as any Transfer
Restricted Securities remain outstanding and during any period in which the Company (i) is not
subject to Section 13 or 15(d) of the Exchange Act, to make available, upon request of any Holder,
to such Holder or beneficial owner of Transfer Restricted Securities in connection with any sale
thereof and any prospective purchaser of such Transfer Restricted Securities designated by such
Holder or beneficial owner, the information required by Rule 144A(d)(4) under the Securities Act in
order to permit resales of such Transfer Restricted Securities pursuant to Rule 144A, and (ii) is
subject to Section 13 or 15 (d) of the Exchange Act, to make all filings required thereby in a
timely manner in order to permit resales of such Transfer Restricted Securities pursuant to Rule
144.

19

 

8. Underwritten Registrations.

     (a) Any Holder of Transfer Restricted Securities who desires to do so may sell Transfer
Restricted Securities (in whole or in part) in an underwritten offering; provided that (i) the
Electing Holders of at least 33-1/3% in aggregate principal amount of the Transfer Restricted
Securities then covered by the Shelf Registration Statement shall request such an offering and (ii)
at least such aggregate principal amount of such Transfer Restricted Securities shall be included
in such offering; and provided, further, that the Company shall not be obligated to participate in
more than one underwritten offering during the Effectiveness Period. Upon receipt of such a
request, the Company shall provide all Holders of Transfer Restricted Securities written notice of
the request, which notice shall inform such Holders that they have the opportunity to participate
in the offering. If any of the Transfer Restricted Securities covered by the Shelf Registration
Statement are to be sold in an underwritten offering, the Managing Underwriters shall be selected
by the Majority Holders.

     (b) No Person may participate in any underwritten offering pursuant to the Shelf Registration
Statement unless such Person (i) agrees to sell such Person’s Notes on the basis reasonably
provided in any underwriting arrangements approved by the Persons entitled hereunder to approve
such arrangements; (ii) completes and executes all questionnaires, powers of attorney, indemnities,
underwriting agreements and other documents reasonably required under the terms of such
underwriting arrangements; and (iii) if such Holder is not then a Notice Holder, such Holder
returns a completed and signed Notice and Questionnaire to the Company in accordance with Section
2(f) hereof within a reasonable amount of time before such underwritten offering.

     (c) The Holders participating in any underwritten offering shall be responsible for any
underwriting discounts and commissions and fees and, subject to Section 5 hereof, expenses of their
own counsel. The Company shall pay all expenses customarily borne by issuers in an underwritten
offering, including but not limited to filing fees, the fees and disbursements of its counsel and
independent public accountants and any printing expenses incurred in connection with such
underwritten offering. Notwithstanding the foregoing or the provisions of Section 4(b)(xxiv)
hereof, upon receipt of a request from the Managing Underwriter or a representative of holders of a
majority of the Transfer Restricted Securities to be included in an underwritten offering to
prepare and file an amendment or supplement to the Shelf Registration Statement and Prospectus in
connection with an underwritten offering, the Company may delay the filing of any such amendment or
supplement for up to 90 days if the Board of Directors of the Company shall have determined in good
faith that the Company has a bona fide business reason for such delay.

9. Miscellaneous.

     (a) Remedies. The Company acknowledges and agrees that any failure by the Company to comply
with its obligations under Section 2 hereof may result in material irreparable injury to the
Initial Purchasers or the Holders for which there is no adequate remedy at law, that it will not be
possible to measure damages for such injuries precisely, and that, in the event of any such
failure, in addition to being entitled to exercise all rights provided to it herein, in the
Indenture or in the Purchase Agreement or granted by law, including recovery of liquidated or other
damages, the Initial Purchasers or any Holder may obtain such relief as may be required to

20

 

specifically enforce the Company’s obligations under Section 2 hereof. The Company further
agrees to waive the defense in any action for specific performance that a remedy at law would be
adequate.

     (b) Actions Affecting Transfer Restricted Securities. The Company shall not, directly or
indirectly, take any action with respect to the Transfer Restricted Securities as a class that
would adversely affect the ability of the Holders of Transfer Restricted Securities to include such
Transfer Restricted Securities in a registration undertaken pursuant to this Agreement.

     (c) No Inconsistent Agreements. The Company has not, as of the date hereof, entered into, nor
shall it, on or after the date hereof, enter into, any agreement with respect to its securities
that is inconsistent with the rights granted to the Holders in this Agreement or otherwise
conflicts with the provisions hereof. In addition, the Company shall not grant to any of its
security holders (other than the Holders of Transfer Restricted Securities in such capacity) the
right to include any of its securities in the Shelf Registration Statement provided for in this
Agreement other than the Transfer Restricted Securities.

     (d) Amendments and Waivers. This Agreement may not be amended, modified or supplemented, and
waivers or consents to or departures from the provisions hereof may not be given, unless the
Company has obtained the written consent of a Majority of Holders; provided, however, that with
respect to any matter that directly or indirectly adversely affects the rights of any Initial
Purchaser hereunder, the Company shall obtain the written consent of each such Initial Purchaser
against which such amendment, qualification, supplement, waiver or consent is to be effective.
Notwithstanding the foregoing (except the foregoing proviso), a waiver or consent to depart from
the provisions hereof with respect to a matter that relates exclusively to the rights of Holders
whose securities are being sold pursuant to a Shelf Registration Statement and does not directly or
indirectly adversely affect the rights of other Holders, may be given by the Majority of Holders,
determined on the basis of Notes being sold rather than registered under such Shelf Registration
Statement.

     (e) Notices. All notices and other communications provided for or permitted hereunder shall
be made in writing by hand delivery, first class mail (registered or certified, return receipt
requested), facsimile transmission, or air courier guaranteeing overnight delivery:

     (i) if to a Holder, at the address set forth on the records of the Registrar (as
defined in the Indenture) or the transfer agent of the Common Stock, as the case may be; and

     (ii) if to the Company, initially at its address set forth in the Purchase Agreement,

With a copy to (which shall not constitute notice):

Pepper Hamilton LLP

3000 Two Logan Square

18th and Arch Streets

Philadelphia, PA 19103-2799

21

 

Facsimile: (215) 981-4750

Attention: Brian M. Katz, Esq.

     (iii) If to the Initial Purchasers at their addresses set forth in the Purchase
Agreement, with a copy to (which shall not constitute notice):

Shearman & Sterling LLP

599 Lexington Avenue

New York, NY 10022

Facsimile: (212) 848-7179

Attention: Joel S. Klaperman, Esq.

All such notices and communications shall be deemed to have been duly given: at the time delivered
by hand, if personally delivered; five Business Days after being deposited in the mail, postage
prepaid, if mailed; when receipt acknowledged, if transmitted by facsimile; and on the next
Business Day, if timely delivered to an air courier guaranteeing overnight delivery.

Any party hereto may change the address for receipt of communications by giving written notice to
the others.

     (f) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon
the successors and assigns of each of the parties, including without limitation and without the
need for an express assignment, subsequent Holders of Transfer Restricted Securities. The Company
hereby agrees to extend the benefit of this Agreement to any Holder and any such Holder may
specifically enforce the provisions of this Agreement as if an original party hereto.

     (g) Counterparts. This Agreement may be executed in any number of counterparts and by the
parties hereto in separate counterparts, each of which when so executed shall be deemed to be an
original and all of which taken together shall constitute one and the same agreement.

     (h) Jurisdiction. The Company agrees that any suit, action or proceeding against the Company
brought by any Holder or Initial Purchaser, the directors, officers, employees, Affiliates and
agents of any Holder or Initial Purchaser, or by any Person who controls any Holder or Initial
Purchaser, arising out of or based upon this Agreement or the transactions contemplated hereby may
be instituted in any State or U.S. federal court in The City of New York and County of New York,
and waives any objection which it may now or hereafter have to the laying of venue of any such
proceeding, and irrevocably submits to the non-exclusive jurisdiction of such courts in any suit,
action or proceeding. The Company hereby appoints Corporation Service Company as its authorized
agent (the “Authorized Agent”) upon whom process may be served in any suit, action or proceeding
arising out of or based upon this Agreement or the transactions contemplated herein which may be
instituted in any State or U.S. federal court in The City of New York and County of New York, by
any Holder or Initial Purchaser, the directors, officers, employees, Affiliates and agents of any
Holder or Initial Purchaser, or by any person who controls any Holder or Initial Purchaser, and
expressly accepts the non-exclusive jurisdiction of any such court in respect of any such suit,
action or proceeding.

22

 

The Company hereby represents and warrants that the Authorized Agent has accepted such
appointment and has agreed to act as said agent for service of process, and the Company agrees to
take any and all action, including the filing of any and all documents that may be necessary to
continue such appointment in full force and effect as aforesaid. Service of process upon the
Authorized Agent shall be deemed, in every respect, effective service of process upon the Company.
The Company further agrees to take any and all action, including the execution and filing of any
and all such documents and instruments, as may be necessary to continue such designation and
appointment in full force and effect so long as any of the Securities shall be outstanding. To the
extent that the Company may acquire any immunity from jurisdiction of any court or from any legal
process (whether through service of notice, attachment prior to judgment, attachment in aid of
execution, execution or otherwise) with respect to itself or its property, it hereby irrevocably
waives such immunity in respect of this Agreement, to the fullest extent permitted by law.
Notwithstanding the foregoing, any action arising out of or based upon this Agreement may be
instituted by any Holder or Initial Purchaser, the directors, officers, employees, Affiliates and
agents of any Holder or Initial Purchaser, or by any Person who controls any Holder or Initial
Purchaser, in any court of competent jurisdiction.

     (i) Notes Held by the Company or Their Affiliates. Whenever the consent or approval of
Holders of a specified percentage of Transfer Restricted Securities is required hereunder, Transfer
Restricted Securities held by the Company or its Affiliates (other than subsequent Holders if such
subsequent Holders are deemed to be Affiliates solely by reason of their holding of such Transfer
Restricted Securities) shall not be counted in determining whether such consent or approval was
given by the Holders of such required percentage.

     (j) Headings. The headings in this Agreement are for convenience of reference only and shall
not limit or otherwise affect the meaning hereof.

     (k) Governing Law. This Agreement shall be governed by and construed in accordance with the
law of the State of New York.

     (l) Severability. If any one or more of the provisions contained herein, or the application
thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and
enforceability of any such provision in every other respect and of the remaining provisions
contained herein shall not be affected or impaired thereby, it being intended that all of the
rights and privileges of the parties shall be enforceable to the fullest extent permitted by law.

     (m) Entire Agreement. This Agreement is intended by the parties as a final expression of
their agreement and intended to be a complete and exclusive statement of the agreement and
understanding of the parties hereto in respect of the subject matter contained herein. There are
no restrictions, promises, warranties or undertakings, other than those set forth or referred to
herein with respect to the registration rights granted by the Company with respect to the Transfer
Restricted Securities. This Agreement supersedes all prior agreements and understandings between
the parties with respect to such subject matter.

23

 

     IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above.

	 	 	 	 	 	 	 
	 	 	DOLLAR FINANCIAL CORP.
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ William M. Athas	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: William M. Athas	 	 
	 

	 	 	 	Title: SVP, Finance	 	 
	 
	 	 	 	 	 	 
	 	 	WACHOVIA CAPITAL MARKETS, LLC 

BEAR, STEARNS & CO. INC. 

JEFFERIES & COMPANY, INC. 

JMP SECURITIES LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	Wachovia Capital Markets, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Mary Louise Guttman	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Mary Louise Guttman	 	 
	 

	 	 	 	Title: Senior Vice President

          Assistant General Counsel	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	Bear, Stearns & Co. Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Paul S. Rosica	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Name: Paul S. Rosica	 	 
	 

	 	 	 	Title: Senior Managing Directorexv10w1

 

EXHIBIT 10.1

EXECUTION COPY

DOLLAR FINANCIAL CORP.

U.S. $175,000,000 AGGREGATE PRINCIPAL AMOUNT

2.875% SENIOR CONVERTIBLE NOTES DUE 2027

PURCHASE AGREEMENT

June 21, 2007

Wachovia Capital Markets, LLC

Bear, Stearns & Co. Inc.

As Representatives of the several Initial Purchasers

c/o

Wachovia Capital Markets, LLC

375 Park Avenue (NY4070)

New York, New York 10152

Ladies and Gentlemen:

          Dollar Financial Corp., a Delaware corporation (the “Company”), proposes, subject to the terms
and conditions stated herein, to issue and sell to the Initial Purchasers named in Schedule I
hereto (each an “Initial Purchaser” and collectively, the “Initial Purchasers”), for whom Wachovia
Capital Markets LLC and Bear, Stearns & Co. Inc. are acting as representatives (in such capacity,
the “Representatives”), U.S. $175,000,000 principal amount of its 2.875% Senior Convertible Notes
Due 2027 (the “Initial Securities”). In addition, the Company has granted to the Initial
Purchasers an over-allotment option to purchase up to an additional $25,000,000 in aggregate
principal amount of its 2.875% Senior Convertible Notes Due 2027 (the “Optional Securities” and,
together with the Initial Securities, the “Securities”).

          The Securities will be convertible on the terms, and subject to the conditions, set forth in
the Indenture (as defined below). As used herein, “Conversion Shares” means the shares of common
stock, par value $0.001 per share, of the Company (the “Common Stock”) to be received by the
holders of the Securities upon conversion of the Securities pursuant to the terms of the Indenture.

          The Securities are to be issued pursuant to an indenture (the “Indenture”) dated as of the
Closing Date (as defined in Section 4 hereto), between the Company and U.S. Bank National
Association, as trustee (the “Trustee”).

          The holders of the Securities will be entitled to the benefits of a resale registration rights
agreement (the “Registration Rights Agreement”), to be dated as of the Closing Date,

1

 

between the
Company and the Initial Purchasers, pursuant to which the Company will agree to register the resale
of the Securities and the Conversion Shares on a resale shelf registration statement pursuant to
Rule 415 under the Securities Act of 1933, as amended (the “Securities Act”), subject to the terms
and conditions therein specified.

          The Company understands that the Initial Purchasers propose to make an offering of the
Securities as soon as the Representatives deem advisable after this Agreement has been executed and
delivered.

          The sale of the Securities to the Initial Purchasers will be made without registration of the
Securities or the Conversion Shares under the Securities Act in reliance upon an exemption from the
registration requirements of the Securities Act pursuant to Rule 144A under the Securities Act.

          1. Offering Documents. The Company has prepared and delivered to the Initial
Purchasers copies of a preliminary offering memorandum, dated June 20, 2007 (the “Preliminary
Offering Memorandum”), and promptly after the execution of this Agreement, the Company will prepare
and deliver to the Initial Purchasers, on the date hereof or the next succeeding day, copies of a
final offering memorandum, dated June 21, 2007 (the “Final Offering Memorandum”).

          Any reference herein to the Time of Sale Disclosure Package (as defined below), the
Preliminary Offering Memorandum or the Final Offering Memorandum shall be deemed to mean and
include all such financial statements and schedules and other information which are incorporated by
reference in the Time of Sale Disclosure Package, the Preliminary Offering Memorandum or the Final
Offering Memorandum as of the date of such Time of Sale Disclosure Package, Preliminary Offering
Memorandum or Final Offering Memorandum, as the case may be; and any reference to “amend,”
“amendment” or “supplement” with respect to the Preliminary Offering Memorandum or the Final
Offering Memorandum shall be deemed to include any documents filed after such date and prior to the
Closing Date under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are
deemed to be incorporated by reference therein.

          At 5:45 p.m. (Eastern time) on the date hereof (the “Time of Sale”), the Company had prepared
the following information (collectively, the “Time of Sale Disclosure Package”): (a) the
Preliminary Offering Memorandum, as amended and supplemented immediately prior to the Time of Sale,
(b) the Pricing Term Sheet (as defined in Section 7) prepared pursuant to Section 7(b) hereof, and
(c) any Supplemental Offering Materials (as defined in Section 6) listed on Schedule II hereto.

          The Company hereby confirms that it has authorized the use of the Time of Sale Disclosure
Package (and any constituent party thereof) and the Final Offering Memorandum in connection with
the offer and sale of the Securities by the Initial Purchasers.

2

 

          2. Representations and Warranties. The Company represents and warrants to, and agrees
with, the Initial Purchasers as set forth below in this Section 2.

     (a) As of the date of the Final Offering Memorandum, as of the date of any amendment or
supplement thereto, or as of the Closing Date (as defined below), the Final Offering
Memorandum did not, and will not, contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; except that the foregoing shall
not apply to statements in or omissions from the Final Offering Memorandum made in reliance
upon and in conformity with information relating to the Initial Purchasers furnished to the
Company in writing by any Initial Purchaser through the Representatives expressly for use in
the Final Offering Memorandum, it being understood and agreed that the only such information
furnished by any of the Initial Purchasers consists of the information described as such in
Section 10(b) hereof.

     (b) At the Time of Sale, the Time of Sale Disclosure Package did not, and at the
Closing Date will not, contain any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; except that the foregoing shall
not apply to statements in or omissions from the Time of Sale Disclosure Package made in
reliance upon and in conformity with information relating to the Initial Purchasers
furnished to the Company in writing by any Initial Purchaser through the Representatives
expressly for use in the Time of Sale Disclosure Package, it being understood and agreed
that the only such information furnished by any of the Initial Purchasers consists of the
information described as such in Section 10(b) hereof. No statement of material fact
included in the Final Offering Memorandum has been omitted from the Time of Sale Disclosure
Package and no statement of material fact included in the Time of Sale Disclosure Package
has been omitted from the Final Offering Memorandum.

     (c) Each of the Company and its subsidiaries has been duly incorporated and is validly
existing as a corporation in good standing under the laws of the jurisdiction in which it is
chartered or organized with full corporate power and authority to own or lease, as the case
may be, and to operate its properties and conduct its business as described in the Time of
Sale Disclosure Package and Final Offering Memorandum, and is duly qualified to do business
as a foreign corporation and is in good standing under the laws of each jurisdiction which
requires such qualification, except where the failure to be so qualified would not have a
material adverse effect on the condition (financial or otherwise), prospects, earnings,
business or properties of the Company and its subsidiaries, taken as a whole, whether or not
arising from transactions in the ordinary course of business.

     (d) All the outstanding shares of capital stock of each subsidiary of the Company have
been duly and validly authorized and issued and are fully paid and nonassessable, and,
except as otherwise set forth in the Time of Sale Disclosure Package and the Final Offering
Memorandum, all outstanding shares of capital stock of the

3

 

subsidiaries of the Company are
owned by the Company, either directly or through
wholly owned subsidiaries free and clear of any perfected security interest or any
other security interests, claims, liens or encumbrances.

     (e) The Company’s authorized equity capitalization is as set forth in the Time of Sale
Disclosure Package and the Final Offering Memorandum; the capital stock of the Company
conforms in all material respects to the description thereof contained in the Time of Sale
Disclosure Package and the Final Offering Memorandum; the Common Stock (including the
Conversion Shares) conforms in all material respects to the description thereof contained in
the Time of Sale Disclosure Package and the Final Offering Memorandum; the outstanding shares of Common Stock have been duly and validly authorized and issued and are fully paid
and nonassessable; the holders of outstanding shares of capital stock of the Company are not
entitled to preemptive or other rights to subscribe for the Securities or the Conversion
Shares; and, except as set forth in the Time of Sale Disclosure Package and the Final
Offering Memorandum or otherwise in connection with the Company’s equity compensation plan
as existing on the date hereof and described in the Time of Sale Disclosure Package and the
Final Offering Memorandum, no options, warrants or other rights to purchase, agreements or
other obligations to issue, or rights to convert any obligations into or exchange any
securities for, shares of capital stock of or ownership interests in the Company are
outstanding.

     (f) The statements under “Part I—Item 3 Legal Proceedings” in the Company’s Annual
Report Form 10-K for the year ended June 30, 2006, under “Part I—Item 1 Legal Proceedings”
in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2006,
under “Part I—Item 1 Legal Proceedings” in the Company’s Quarterly Report on Form 10-Q for
the quarter ended December 31, 2006, and under “Part I—Item 1 Legal Proceedings” in the
Company’s quarterly Report on Form 10-Q for the quarter ended March 31, 2007, in each case
incorporated by reference in the Time of Sale Disclosure Package and the Final Offering
Memorandum, insofar as such statements summarize legal matters, agreements, documents or
proceedings discussed therein, are accurate in all material respects and fair summaries of
such legal matters, agreements, documents or proceedings.

     (g) The Company is not and, after giving effect to the offering and sale of the
Securities, will not be an “investment company” as defined in the Investment Company Act of
1940, as amended.

     (h) No consent, approval, authorization, filing with or order of any court or
governmental agency or body is required in connection with the transactions contemplated
herein, or for the due execution, delivery or performance of the Indenture by the Company,
except such as have already been obtained.

     (i) This Agreement has been duly authorized, executed and delivered by the Company.

4

 

     (j) The Registration Rights Agreement has been duly authorized, and when executed and
delivered by the Company and the Initial Purchasers, will constitute a valid and binding
agreement of the Company, enforceable against the Company in accordance
with its terms, except as the enforcement thereof may be limited by bankruptcy,
insolvency (including, without limitation, all laws relating to fraudulent transfers),
reorganization, moratorium or similar laws affecting enforcement of creditors’ rights
generally and except as enforcement thereof is subject to general principles of equity
(regardless of whether enforcement is considered in a proceeding in equity or at law) (the
“Enforceability Exceptions”).

     (k) The Indenture has been duly authorized by the Company and, when executed and
delivered by the Company and the Trustee, will constitute a valid and binding agreement of
the Company, enforceable against the Company in accordance with its terms, except as the
enforcement thereof may be limited by the Enforceability Exceptions.

     (l) The Securities have been duly authorized and, on the Closing Date, will have been
duly executed by the Company and, when authenticated, issued and delivered in the manner
provided for in the Indenture and delivered against payment of the purchase price therefor
as provided in this Agreement, will constitute valid and binding obligations of the Company,
enforceable against the Company in accordance with their terms, except as the enforcement
thereof may be limited by the Enforceability Exceptions.

     (m) The Conversion Shares have been duly and validly authorized and reserved for
issuance and, when issued and delivered in accordance with the provisions of the Securities
and the Indenture, will be duly and validly issued, fully paid and nonassessable and will
conform to the description of the Common Stock contained in the Time of Sale Disclosure
Package and the Final Offering Memorandum.

     (n) Except as disclosed in the Time of Sale Disclosure Package, since the date of the
latest audited financial statements included in the Time of Sale Disclosure Package, there
has been no material adverse change, nor any development or event involving a prospective
material adverse change, in the condition (financial or other), business, properties or
results of operations of the Company and its subsidiaries, taken as a whole, and except as
disclosed or contemplated by the Time of Sale Disclosure Package, there has been no dividend
or distribution of any kind declared, paid or made by the Company on any class of its
capital stock.

     (o) Neither the execution, delivery and performance by the Company of this Agreement
nor the consummation of the transactions herein contemplated will conflict with, result in a
breach or violation of, or imposition of any lien, charge or encumbrance upon any property
or assets of the Company or any of its subsidiaries pursuant to, (a) the charter or bylaws
of the Company or any of its subsidiaries, (b) the terms of any indenture, contract, lease,
mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which the Company or any of its subsidiaries is a party
or bound or to which its or their property is subject, or (c) any statute, law, rule,
regulation, judgment, order or decree applicable to the Company or any of its subsidiaries
of any court, regulatory body, administrative agency, governmental body, arbitrator or other
authority having jurisdiction over the Company or

5

 

any of its subsidiaries or any of its or their properties, except with respect to
clauses (b) and (c) above for such conflicts, breaches, violations or impositions that would
not have a material adverse effect on the condition (financial or otherwise), prospects,
earnings, business or properties of the Company and its subsidiaries, taken as a whole,
whether or not arising from transactions in the ordinary course of business.

     (p) None of the Company, its affiliates or any person acting on its or any of their
behalf (other than the Initial Purchasers acting in their capacity as such) has engaged or
will engage, in connection with the offering of Securities, in any form of general
solicitation or general advertising within the meaning of Rule 502(c) under the Securities
Act.

     (q) The Securities and the Indenture will conform in all material respects to the
respective statements relating thereto contained in the Time of Sale Disclosure Package and
the Final Offering Memorandum and will be in substantially the respective forms last
delivered to the Initial Purchasers prior to the date of this Agreement.

     (r) The consolidated historical financial statements and schedules of the Company and
its consolidated subsidiaries included in the Final Offering Memorandum and the Time of Sale
Disclosure Package present fairly in all material respects the financial condition, results
of operations and cash flows of the Company as of the dates and for the periods indicated,
comply as to form with the applicable accounting requirements of the Securities Act and have
been prepared in conformity with U.S. generally accepted accounting principles applied on a
consistent basis throughout the periods involved (except as otherwise noted therein); all
pro forma or similar adjustments to historical financial data set forth in the Final
Offering Memorandum and the Time of Sale Disclosure Package (a) comply as to form in all
material respects with the applicable requirements of Regulation S-X under the Securities
Act, (b) have been prepared in accordance with the Commission’s rules and guidelines with
respect to pro forma financial statements and (c) have been properly computed in the basis
described therein; all other financial data in the Final Offering Memorandum and the Time of
Sale Disclosure Package are accurately presented and prepared on a basis consistent with the
financial statements included in the Final Offering Memorandum and the Time of Sale
Disclosure Package and the books and records of the Company and its subsidiaries.

     (s) No action, suit or proceeding by or before any court or governmental agency,
authority or body or any arbitrator involving the Company or any of its subsidiaries or its
or their property is pending or, to the best knowledge of the Company, threatened that (a)
could reasonably be expected to have a material adverse effect on the performance of this
Agreement or the consummation of any of the transactions contemplated hereby or (b) could
reasonably be expected to have a material adverse effect on the condition (financial or
otherwise), prospects, earnings, business or

6

 

properties of the Company and its subsidiaries,
taken as a whole, whether or not arising from transactions in the ordinary course of
business, except as set forth in or contemplated in the Time of Sale Disclosure Package and
the Final Offering Memorandum (exclusive of any supplement thereto).

     (t) Each of the Company and each of its subsidiaries owns or leases all such properties
as are necessary to the conduct of its operations as presently conducted.

     (u) Neither the Company nor any subsidiary is in violation or default of (a) any
provision of its charter or bylaws, (b) the terms of any indenture, contract, lease,
mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which it is a party or bound or to which its property
is subject (including, without limitation, the 9.75% Senior Notes due 2011 of Dollar
Financial Group, Inc. or the related indenture, and the new credit facilities dated October
30, 2006) or (c) any statute, law, rule, regulation, judgment, order or decree of any court,
regulatory body, administrative agency, governmental body, arbitrator or other authority
having jurisdiction over the Company or such subsidiary or any of its properties, as
applicable, except with respect to clauses (b) and (c) above for such violations or defaults
that would not have a material adverse effect on the condition (financial or otherwise),
prospects, earnings, business or properties of the Company and its subsidiaries, taken as a
whole, whether or not arising from transactions in the ordinary course of business.

     (v) Ernst & Young LLP, KPMG LLP, BDO Dunwoody LLP and Mr. Robert Wilson, who have
certified certain financial statements of the Company and its consolidated subsidiaries and
delivered their reports with respect to certain financial statements and schedules included
in the Time of Sale Disclosure Package and the Final Offering Memorandum, are independent
registered public accountants with respect to the Company within the meaning of the
Securities Act and the Exchange Act and the applicable rules and regulations thereunder.

     (w) The Company has filed all foreign, federal, state and local tax returns that are
required to be filed or has requested extensions thereof (except in any case in which the
failure so to file would not have a material adverse effect on the condition (financial or
otherwise), prospects, earnings, business or properties of the Company and its subsidiaries,
taken as a whole, whether or not arising from transactions in the ordinary course of
business and except as set forth in or contemplated in the Time of Sale Disclosure Package
and the Final Offering Memorandum (exclusive of any supplement thereto)) and has paid all
taxes required to be paid by it and any other assessment, fine or penalty levied against it,
to the extent that any of the foregoing is due and payable, except for any such assessment,
fine or penalty that is currently being contested in good faith or as would not have a
material adverse effect on the condition (financial or otherwise), prospects, earnings,
business or properties of the Company and its subsidiaries, taken as a whole, whether or not
arising from transactions in the ordinary course of business, except as set forth in or
contemplated in the Time of Sale Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto).

7

 

     (x) No labor problem or dispute with the employees of the Company or any of its
subsidiaries exists or, to the Company’s knowledge, is threatened or imminent, and the
Company is not aware of any existing or imminent labor disturbance by the employees of any
of its or its subsidiaries’ principal suppliers, contractors or customers, that could have a
material adverse effect on the condition (financial or otherwise), prospects, earnings,
business or properties of the Company and its subsidiaries, taken as a whole, whether or
not arising from transactions in the ordinary course of business, except as set forth
in or contemplated in the Time of Sale Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto).

     (y) The Company and each of its subsidiaries are insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent
and customary in the businesses in which they are engaged; all policies of insurance and
fidelity or surety bonds insuring the Company or any of its subsidiaries or their respective
businesses, assets, employees, officers and directors are in full force and effect; the
Company and its subsidiaries are in compliance with the terms of such policies and
instruments in all material respects; and there are no claims by the Company or any of its
subsidiaries under any such policy or instrument as to which any insurance company is
denying liability or defending under a reservation of rights clause; and neither the Company
nor any such subsidiary has any reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage
from similar insurers as may be necessary to continue its business at a cost that would not
have a material adverse effect on the condition (financial or otherwise), prospects,
earnings, business or properties of the Company and its subsidiaries, taken as a whole,
whether or not arising from transactions in the ordinary course of business, except as set
forth in or contemplated in the Time of Sale Disclosure Package and the Final Offering
Memorandum (exclusive of any supplement thereto).

     (z) No subsidiary of the Company is currently prohibited, directly or indirectly, from
paying any dividends to the Company, from making any other distribution on such subsidiary’s
capital stock to the Company, from repaying to the Company any loans or advances to such
subsidiary from the Company or from transferring any of such subsidiary’s property or assets
to the Company or any other subsidiary of the Company, except as described in or
contemplated in the Time of Sale Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto).

     (aa) The Company and its subsidiaries possess adequate licenses, certificates, permits
and other authorizations issued by the appropriate federal, state or foreign regulatory
authorities necessary to conduct their respective businesses, and neither the Company nor
any such subsidiary has received any notice of proceedings relating to the revocation or
modification of any such license, certificate, permit or authorization which, singly or in
the aggregate, if the subject of an unfavorable decision, ruling or finding, would have a
material adverse effect on the condition (financial or otherwise), prospects, earnings,
business or properties of the Company and its subsidiaries, taken as a whole, whether or not
arising from transactions in the ordinary course of business, except as set

8

 

forth in or
contemplated in the Time of Sale Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto).

     (bb) The Company and each of its subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that (a) transactions are executed in
accordance with management’s general or specific authorizations; (b) transactions are
recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain asset
accountability; (c) access to assets is permitted only in accordance with management’s
general or specific authorization and (d) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences. Since the date of the latest audited financial statements
included or incorporated by reference in the Time of Sale Disclosure Package, there has been
no change in the Company’s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company’s internal control over
financial reporting;

     (cc) The Company has not taken, directly or indirectly, any action designed to or that
would constitute or that might reasonably be expected to cause or result in, under the
Exchange Act or otherwise, stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Securities or the Conversion Shares.

     (dd) The Company and its subsidiaries are (a) in compliance with any and all applicable
foreign, federal, state and local statute, rule, regulation, decision or order of any
governmental agency or body or any court relating to the use, disposal or release of
hazardous or toxic substances or wastes, pollutants or contaminants or relating to the
protection of human health and safety or the environment (“Environmental Laws”), (b) have
received and are in compliance with all permits, licenses or other approvals required of
them under applicable Environmental Laws to conduct their respective businesses and (c) have
not received notice of any actual or potential liability under any Environmental Law, except
where such non-compliance with Environmental Laws, failure to receive required permits,
licenses or other approvals or liability would not, individually or in the aggregate, have a
material adverse effect on the condition (financial or otherwise), prospects, earnings,
business or properties of the Company and its subsidiaries, taken as a whole, whether or not
arising from transactions in the ordinary course of business, except as set forth in or
contemplated in the Time of Sale Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto). Except as set forth in the Time of Sale Disclosure
Package and the Final Offering Memorandum, neither the Company nor any of its subsidiaries
have been named as a “potentially responsible party” under the Comprehensive Environmental
Response, Compensation, and Liability Act of 1980, as amended.

     (ee) Except as disclosed in the Time of Sale Disclosure Package and the Final Offering
Memorandum, neither the Company nor any of its subsidiaries is in violation of any
Environmental Law, owns or operates any real property contaminated with any substance that
is subject to any Environmental Law, is liable for any off-site disposal or

9

 

contamination
pursuant to any Environmental Laws or is subject to any claim relating to any environmental
laws, which violation, contamination, liability or claim, individually or in the aggregate,
would have a material adverse effect on the condition (financial or otherwise), prospects,
earnings, business or properties of the Company and its subsidiaries, taken as a whole,
whether or not arising from transactions in the ordinary course of business; and neither the
Company nor any of its subsidiaries is aware of any pending investigation which might lead
to such a claim.

     (ff) The Securities will not be of the same class (within the meaning of Rule 144A
under the Securities Act (“Rule 144A”)) as any other securities of the Company which are
listed on a national securities exchange registered under Section 6 of the Exchange Act or
quoted in a U.S. automated inter-dealer quotation system.

     (gg) Assuming the accuracy of the representations and warranties of the Initial
Purchasers contained in Section 5 and their compliance with the agreements set forth
therein, no registration under the Securities Act of the Securities or the Conversion
Shares, or qualification of the Indenture under the 1939 Act (as defined below) is required
for the offer and sale of the Securities to or by the Initial Purchasers in the manner
contemplated herein, in the Time of Sale Disclosure Package and the Final Offering
Memorandum

     (hh) The Initial Purchasers have received a lock-up agreement substantially in the form
of Exhibit B hereto signed by each person listed in Schedule IV hereto.

     (ii) The documents incorporated by reference in the Time of Sale Disclosure Package and
in the Final Offering Memorandum, when they became effective or were filed with the
Commission, as the case may be, conformed in all material respects to the requirements of
the Securities Act or the Exchange Act, as applicable, and were filed on a timely basis with
the Commission and none of such documents contained an untrue statement of a material fact
or omitted to state a material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading; any further documents so
filed and incorporated by reference in the Time of Sale Disclosure Package or in the Final
Offering Memorandum, when such documents are filed with the Commission, will conform in all
material respects to the requirements of the Exchange Act, and will not contain an untrue
statement of a material fact or omit to state a material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not
misleading.

     (jj) The Company has established and maintains disclosure controls and procedures (as
defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) and such controls and
procedures are effective in ensuring that material information relating to the Company,
including its subsidiaries, is made known to the principal executive officer and the
principal financial officer. The Company has utilized such controls and procedures in
preparing and evaluating the disclosures in the Time of Sale Disclosure Package and in the
Final Offering Memorandum.

10

 

     (kk) The minimum funding standard under Section 302 of the Employee Retirement Income
Security Act of 1974, as amended, and the regulations and published interpretations
thereunder (“ERISA”), has been satisfied to the extent applicable by each “pension plan” (as
defined in Section 3(2) of ERISA) which has been established or maintained by the Company
and/or one or more of its subsidiaries, and each such plan which is intended to be qualified
under Section 401 of the Internal Revenue Code of 1986, as amended (the “Code”), has
obtained a favorable determination or opinion letter from the Internal Revenue Service on
its qualification; each of the Company and its subsidiaries has fulfilled its obligations,
if any, under Section 515 of ERISA; neither the
Company nor any of its subsidiaries maintains or is required to contribute to a
“welfare plan” (as defined in Section 3(1) of ERISA) which provides retiree or other
post-employment welfare benefits or insurance coverage (other than “continuation coverage”
(as defined in Section 602 of ERISA)); each pension plan and welfare plan established or
maintained by the Company and/or one or more of its subsidiaries is in compliance in all
material respects with the currently applicable provisions of ERISA and the Code; and
neither the Company nor any of its subsidiaries has incurred or could reasonably be expected
to incur any withdrawal liability under Section 4201 of ERISA, any liability under Section
4062, 4063 or 4064 of ERISA or any other liability under Title IV of ERISA.

     (ll) There is and has been no failure on the part of the Company and any of the
Company’s directors or officers, in their capacities as such, to comply in any material
respect with any provision of the Sarbanes-Oxley Act and the rules and regulations
promulgated in connection therewith, including Section 402 related to loans and Sections 302
and 906 related to certifications.

     (mm) Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is aware of or has taken any action, directly or indirectly, that would result
in a violation by such persons of the FCPA, including, without limitation, making use of the
mails or any means or instrumentality of interstate commerce corruptly in furtherance of an
offer, payment, promise to pay or authorization of the payment of any money, or other
property, gift, promise to give or authorization of the giving of anything of value to any
“foreign official” (as such term is defined in the FCPA) or any foreign political party or
official thereof or any candidate for foreign political office, in contravention of the FCPA
and the Company, its subsidiaries and, to the knowledge of the Company, its affiliates have
conducted their businesses in compliance with the FCPA and have instituted and maintain
policies and procedures designed to ensure, and which are reasonably expected to continue to
ensure, continued compliance therewith. The “FCPA” means the Foreign Corrupt Practices Act
of 1977, as amended, and the rules and regulations thereunder.

     (nn) The operations of the Company and its subsidiaries are and have been conducted at
all times in compliance in all material respects with applicable financial recordkeeping and
reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all jurisdictions, the

11

 

rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered
or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and no
action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or any of its subsidiaries with respect to the Money
Laundering Laws is pending or, to the best knowledge of the Company, threatened.

     (oo) Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the Office of
Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will
not directly or indirectly use the proceeds of the offering, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other
person or entity, for the purpose of financing the activities of any person currently
subject to any U.S. sanctions administered by OFAC.

     (pp) There are no stamp or other issuance or transfer taxes or duties or other similar
fees or charges required to be paid in connection with the execution and delivery of this
Agreement or the issuance or sale by the Company of the Securities or upon the issuance of
Common Stock upon the conversion thereof.

     (qq) The Company and its subsidiaries own, possess, license or have other rights to
use, on reasonable terms, adequate patents, patent applications, trade and service marks,
trade and service mark registrations, trade names, copyrights, licenses, inventions, trade
secrets, technology, know-how and other intellectual property (collectively, the
“Intellectual Property”) necessary for the conduct of the Company’s business as now
conducted or as proposed in the Time of Sale Disclosure Package and the Final Offering
Memorandum to be conducted. There is no pending or, to the Company’s best knowledge,
threatened action, suit, proceeding or claim by others challenging the Company’s rights in
or to any such Intellectual Property, and the Company is unaware of any facts which would
form a reasonable basis for any such claim, and there is no pending or, to the Company’s
knowledge, threatened action, suit, proceeding or claim by others that the Company infringes
or otherwise violates any patent, trademark, copyright, trade secret or other proprietary
rights of others, and the Company is unaware of any other fact which would form a reasonable
basis for any such claim.

          Any certificate signed by any officer of the Company and delivered to the Representatives or
counsel for the Initial Purchasers in connection with the offering of the Securities shall be
deemed a representation and warranty by the Company, as to matters covered thereby, to the Initial
Purchasers.

          3. Purchase and Sale.

          (a) Subject to the terms and conditions and in reliance upon the representations and
warranties herein set forth, the Company agrees to sell the Initial Securities to the Initial
Purchasers, and each Initial Purchaser, severally and not jointly, agrees to purchase

12

 

from the
Company, the respective principal amount of the Securities opposite the name of such Initial
Purchaser as set forth in Schedule I hereto, plus any additional number of Initial Securities which
such Initial Purchaser may become obligated to purchase pursuant to the provisions of Section 11
hereof, subject to such adjustments among the Initial Purchasers as the Representatives in their
sole discretion shall make to eliminate any sales or purchases of fractional Securities, in each
case at a purchase price equal to 97% of the principal amount of the Securities (the “Purchase
Price”)

          (b) In addition, on the basis of the representations, warranties, agreements and covenants
herein contained and subject to the terms and conditions herein set forth, the Company hereby
grants an option to the Initial Purchasers, severally and not jointly, to purchase up to U.S.

          $25,000,000 aggregate principal amount of Optional Securities at the Purchase Price, plus
accrued and unpaid interest from the Closing Date to, but excluding, the applicable Option Closing
Date (as defined below). The option hereby granted will expire at 11:59 P.M. (New York City time)
on the 30th day after the date hereof and may be exercised, in whole or in part, from time to time
solely for the purpose of covering over-allotments that may be made in connection with the offering
and distribution of the Initial Securities upon notice by the Representatives to the Company
setting forth the number of Optional Securities as to which the several Initial Purchasers are then
exercising the option and the time and date of payment and delivery for such Optional Securities.
Any such time and date of delivery (an “Option Closing Date”) shall be determined by the
Representatives, but shall not be later than seven full business days after the exercise of said
option, nor in any event prior to the Closing Date.

          4. Delivery and Payment. Delivery of and payment for the Initial Securities shall be
made at the offices of Shearman & Sterling LLP, 599 Lexington Avenue, New York, New York 10022, at
10:00 a.m., New York City time, on June 27, 2007, or at such time on such later date not more than
three Business Days after the foregoing date as the Representatives shall designate, which date and
time may be postponed by agreement among the Representatives and the Company (such date and time of
delivery and payment for the Initial Securities being herein called the “Closing Date”). Delivery
of the Securities shall be made to the Representatives, registered in such names and in such
denominations as the Representatives shall request in writing at least one full Business Day prior
to the Closing Date, against payment by the Initial Purchasers of the Purchase Price to or upon the
order of the Company by wire transfer payable in same-day funds to the account specified by the
Company. Delivery of the Securities shall be made through the facilities of The Depository Trust
Company unless the Representatives shall otherwise instruct the Company.

          In addition, in the event that any or all of the Optional Securities are purchased by the
Initial Purchasers, payment of the purchase price for, and delivery of certificates for, such
Optional Securities shall be made at 9:00 A.M. (New York City time) at the above-mentioned offices,
or at such other place as shall be agreed upon by the Representatives and the Company, on each
Option Closing Date as specified in the notice from the Representatives to the Company.

          5. Offering by Initial Purchasers and the Initial Purchasers’ Representations and
Warranties.

13

 

          (a) Each Initial Purchaser acknowledges that neither the Securities nor the Conversion Shares
have been, or will be, registered under the Securities Act and may not be offered or sold within
the United States or to, or for the account or benefit of, U.S. persons, except pursuant to an
exemption from, or in a transaction not subject to, the registration requirements of the Securities
Act.

          (b) Each Initial Purchaser, severally and not jointly, represents and warrants to and agrees
with the Company that:

     (i) It is a qualified institutional buyer as defined Rule 144A (a “QIB”).

     (ii) It (including any person acting on its behalf) has solicited offers and will
solicit offers for the Securities only from, and will offer the Securities only to persons
that it reasonably believes to be, QIBs, and such Initial Purchaser has taken or will take
reasonable steps to ensure that each purchaser of the Securities is aware that the
Securities are being offered and sold in reliance upon the representations and warranties
deemed to have been made by such purchaser as provided in the Preliminary Offering
Memorandum and the Final Offering Memorandum under the caption “Transfer Restrictions” and
such Initial Purchaser (and any person acting on its behalf) has taken or will take
reasonable steps to ensure that the purchaser of such Securities is aware that such sale is
being made in reliance upon Rule 144A. Such Initial Purchaser also agrees that it will not
offer, sell or deliver any of the Securities in any jurisdiction outside of the United
States except under circumstances that will result in compliance with the applicable laws
thereof.

     (iii) Neither it nor any person acting on its behalf will offer or sell the Securities
using any form of general solicitation or general advertising (within the meaning of
Regulation D) or in any manner involving a public offering within the meaning of Section
4(2) under the Securities Act

          (c) Each Initial Purchaser acknowledges the statements in the fourteenth through eighteenth
paragraphs under “Plan of Distribution” (the “European Selling Restrictions”) in the Preliminary
Offering Memorandum and, severally and not jointly, agrees to comply with the European Selling
Restrictions and affirms and agrees to each of the representations and agreements made therein as
if they were made herein.

          6. Supplemental Offering Materials.

          (a) Without the prior written consent of the Representatives, the Company has not given and
will not give to any prospective purchaser of the Securities any “written communication” (within
the meaning of Rule 405 under the Securities Act) prepared by or on behalf of the Company, or used
or referred to by the Company, that constitutes an offer to sell or a solicitation of an offer to
buy the Securities, including, without limitation, any road show relating to the Securities that
constitutes such a written communication (“Supplemental Offering Materials”) other than the
documents that constitute the Time of Sale Disclosure Package or the Final Offering Memorandum
(including any amendments or supplements thereto). Any such

14

 

Supplemental Offering Materials
consented to by the Representatives are listed on Schedule II hereto.

          (b) The Company represents that as of the Time of Sale, no individual Supplemental Offering
Materials, when considered together with the Time of Sale Disclosure Package, included any untrue
statement of a material fact or omitted to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading.

          (c) The Company represents and agrees that any individual Supplemental Offering Materials, as
of its issue date and at all subsequent times through the completion of the offering and sale of
the Securities, did not, does not and will not include any information that
conflicted, conflicts or will conflict with the information contained in the Preliminary
Offering Memorandum or the Final Offering Memorandum.

          7. Agreements. The Company agrees with the Initial Purchasers that:

          (a) During the period referred to in subparagraph (c) below, the Company will not amend or
supplement the Time of Sale Disclosure Package or the Final Offering Memorandum, other than by
filing documents under the Exchange Act that are incorporated by reference therein, without the
prior written consent of the Representatives; provided, however, that prior to the
completion of the Offering Period, the Company will not file any document under the Exchange Act
that is incorporated by reference in the Time of Sale Disclosure Package or the Final Offering
Memorandum unless, prior to such proposed filing, the Company has furnished to the Representatives
a copy of such document for their review reasonably in advance of such filing and the
Representatives have not reasonably objected to the filing of such document. The Company will
promptly advise the Representatives when any document filed under the Exchange Act that is
incorporated by reference in the Time of Sale Disclosure Package or the Final Offering Memorandum
shall have been filed with the Commission.

          (b) The Company will prepare a final term sheet that contains solely a description of the
Securities and the offering thereof (the “Pricing Term Sheet”), in a form approved by the
Representatives and attached as Schedule III hereto.

          (c) If, prior to the completion of the sale and distribution of the Securities by the Initial
Purchasers (the “Offering Period”), any event occurs as a result of which the Time of Sale
Disclosure Package would include any untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein, in the light of the circumstances under
which they were made, not misleading, the Company will (1) notify the Initial Purchasers so that
any use of the Time of Sale Disclosure Package may cease until it is amended or supplemented; (2)
amend or supplement the Time of Sale Disclosure Package to correct such statement or omission; and
(3) supply any amendment or supplement to the Initial Purchasers in such quantities as the Initial
Purchasers may reasonably request.

          (d) If, during the Offering Period, any event occurs as a result of which the Final Offering
Memorandum as then amended or supplemented would contain any untrue

15

 

statement of a material fact or
omit to state any material fact necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, or if it shall be necessary to amend or
supplement the Final Offering Memorandum to comply with applicable law, the Company promptly will
(1) notify the Initial Purchasers of any such event, (2) prepare and file with the Commission,
subject paragraph (a) of this Section 7, an amendment or supplement which will correct such
statement or omission or effect such compliance and (3) supply any supplemented Final Offering
Memorandum to the Initial Purchasers in such quantities as the Initial Purchasers may reasonably
request.

          (e) During the Offering Period, the Company will furnish to the Initial Purchasers and to
counsel for the Initial Purchasers promptly, without charge, as many copies of the materials
contained in the Time of Sale Disclosure Package and the Final Offering Memorandum and any
amendments and supplements thereto as they may reasonably request.

          (f) The Company will not, without the prior written consent of Wachovia Capital Markets, LLC
and Bear, Stearns & Co. Inc., for a period of 60 days after the date of this Agreement (the
“Lock-Up Period”) offer, sell, contract to sell, pledge, or otherwise dispose of (or enter into any
transaction which is designed to, or might reasonably be expected to, result in the disposition
(whether by actual disposition or effective economic disposition due to cash settlement or
otherwise) by the Company), directly or indirectly, including the filing (or participation in the
filing) of a registration statement with the Commission in respect of, or establish or increase a
put equivalent position or liquidate or decrease a call equivalent position within the meaning of
Section 16 of the Exchange Act and the rules and regulations of the Commission promulgated
thereunder with respect to, any shares of Common Stock, preferred stock, or other capital stock
(collectively, “Capital Stock”) or any securities convertible into, or exercisable or exchangeable
for such Capital Stock, or publicly announce an intention to effect any such transaction,
provided, however, that the Company (a) may issue and sell restricted stock or
restricted stock units, and grant options pursuant to any employee stock option plan or stock
ownership plan (including upon the exercise or conversion of any securities issued pursuant to any
employee stock option plan or stock ownership plan), dividend reinvestment plan of the Company in
effect at the date of this Agreement or to any employee or director of the Company (or its
subsidiaries) provided that such issuance is approved by the compensation committee of the
Company’s board of directors, (b) may issue Common Stock issuable upon conversion of securities or
the exercise of warrants outstanding at the date hereof and (c) may issue up to $20 million of
Common Stock or any security convertible into, or exercisable or exchangeable for Common Stock,
solely for the purpose of completing an acquisition. In addition, the Company will not, during
such 60 day period, accept the disposition or sale of shares of Lock-Up Securities to the Company
by persons part to the agreements referred to in Section 2(hh) hereof.

          (g) The Company will comply in all material respects with all applicable securities and other
applicable laws, rules and regulations, including, without limitation, the Sarbanes-Oxley Act, and
will use its best efforts to cause the Company’s directors and officers, in their capacities as
such, to comply with such laws, rules and regulations, including, without limitation, the
provisions of the Sarbanes-Oxley Act.

16

 

          (h) The Company will reserve and keep available at all times, free of pre-emptive rights, the
full number of shares of Common Stock issuable upon conversion of the Securities.

          (i) None of the Company or any of its affiliates, nor any person acting on its or their behalf
(other than any Initial Purchaser acting in its capacity as such) will, directly or indirectly,
make offers or sales of any security, or solicit offers to buy any security, under circumstances
that would require the registration of the Securities or the Conversion Shares under the Securities
Act.

          (j) None of the Company or any of its affiliates, nor any person acting on its or their behalf
(other than any Initial Purchaser acting in its capacity as such) will engage in any form of
general solicitation or general advertising (within the meaning of Regulation D) in connection with
any offer or sale of the Securities or the Conversion Securities.

          (k) For so long as any of the Securities are “restricted securities” within the meaning of
Rule 144(a)(3) under the Securities Act, the Company shall provide to any holder of the Securities
or to any prospective purchaser of the Securities designated by any holder, upon request of such
holder or prospective purchaser, information required to be provided by Rule 144A(d)(4) under the
Securities Act if, at the time of such request, the Company is not subject to the reporting
requirements under Section 13 or 15(d) of the Exchange Act.

          (l) The Company will use its best efforts to list, subject to notice of issuance, the
Conversion Shares on the NASDAQ Global Select Market (“NASDAQ”).

          (m) The Company will cooperate with the Initial Purchasers and use its best efforts to permit
the Securities to be eligible for clearance and settlement through the facilities of the Depository
Trust Company.

          (n) The Company will not take, directly or indirectly, any action designed to or that would
constitute or that might reasonably be expected to cause or result in, under the Exchange Act or
otherwise, stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of the Securities or the Conversion Shares.

          (o) The Company will, in cooperation with the Initial Purchasers, qualify the Securities and
the Conversion Shares for offering and sale, or obtain an exemption for the Securities and the
Conversion Shares to be offered and sold under the applicable securities laws of such states and
other jurisdictions (domestic or foreign) as the Representatives may designate and will maintain
the effectiveness of such qualifications and exemptions for so long as required for the
distribution of the Securities (but in no event for less than one year from the date of this
Agreement); provided, however, that the Company shall not be obligated to file any
general consent to service of process or to qualify as a foreign corporation or as a dealer in
securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in
respect of doing business in any jurisdiction in which it is not otherwise so subject. In each
jurisdiction in which the Securities have been so qualified or exempt, the Company will file such
statements and reports as may be required by the laws of such jurisdiction to continue such
qualification or

17

 

exemption, as the case may be, in effect for so long as required for the
distribution of the Securities (but in no event for less than one year from the date of this
Agreement).

          (p) The Company agrees to pay the costs and expenses relating to the following matters: (i)
the preparation, printing or reproduction of the Final Offering Memorandum, the Time of Sale
Disclosure Package, any Supplemental Offering Materials and each amendment or supplement to any of
them; (ii) the printing (or reproduction) and delivery (including postage, air freight charges and
charges for counting and packaging) of such copies of the Final Offering Memorandum, the Time of
Sale Disclosure Package, any Supplemental Offering Materials and all amendments or supplements to
any of them, as may, in each case, be reasonably requested for use in connection with the offering
and sale of the Securities; (iii) the preparation, printing, authentication, issuance and delivery
of certificates for the Securities, including any stamp or transfer taxes in connection with the
original issuance and sale of the Securities; (iv) the printing (or reproduction) and delivery of
this Agreement, any blue sky memorandum and all other agreements or documents printed (or
reproduced) and delivered in connection with the offering of the Securities; (v) any registration
of the Conversion Shares
under the Exchange Act and any listing of the Conversion Securities on NASDAQ; (vi) any
registration or qualification of the Securities or the Conversion Shares for offer and sale under
the securities or blue sky laws (including filing fees and the reasonable fees and expenses of
counsel for the Initial Purchasers relating to such registration and qualification); (vii) any
filings required to be made with the National Association of Securities Dealers, Inc. (including
filing fees and the reasonable fees and expenses of counsel for the Initial Purchasers relating to
such filings); (viii) the transportation and other expenses incurred by or on behalf of Company
representatives in connection with presentations to prospective purchasers of the Securities; (ix)
the fees and expenses of the Company’s accountants and the fees and expenses of counsel (including
local and special counsel) for the Company; (x) the fees and expenses of the Trustee, including the
fees and disbursements of counsel for the Trustee in connection with the Indenture and the
Securities; (xi) all other costs and expenses incident to the performance by the Company of its
obligations hereunder; and (xii) all other reasonable costs and expenses incident to the
performance by the Company of its obligations hereunder.

          8A. Conditions to the Obligations of the Initial Purchasers. The obligation of the
several Initial Purchasers to purchase the Securities shall be subject to the accuracy of the
representations and warranties on the part of the Company contained herein as of the date of this
Agreement and as of the Closing Date, to the accuracy of the statements of the Company made in any
certificates pursuant to the provisions hereof, to the performance by the Company of its
obligations hereunder and to the following additional conditions:

          (a) No Initial Purchaser shall have advised the Company that the Time of Sale Disclosure
Package or the Final Offering Memorandum, or any amendment thereof or supplement thereto, or any
Supplemental Offering Materials, contains an untrue statement of fact which, in your opinion, is
material, or omits to state a fact which, in your opinion, is material and is required to be stated
therein or necessary to make the statements therein not misleading.

18

 

          (b) On the Closing Date, there shall have been furnished to the Initial Purchasers, the
opinion of Pepper Hamilton LLP, counsel for the Company, dated the Closing Date and addressed to
the Initial Purchasers, in the form of Schedule V.

          (c) On the Closing Date, there shall have been furnished to the Initial Purchasers, the
opinion of Mr. Roy Hibberd, Senior Vice President and General Counsel of the Company, dated the
Closing Date and addressed to the Initial Purchasers, to the effect that:

     (i) Each of the subsidiaries has been duly incorporated in its state of
incorporation as set forth in an exhibit thereto;

     (ii) Each of the subsidiaries has the corporate power and authority to own its
properties and conduct its business as described in the Time of Sale Disclosure
Package and the Final Offering Memorandum;

     (iii) All of the outstanding shares of capital stock of each subsidiary have
been duly and validly authorized and issued and are fully paid and nonassessable,
and, except as set forth in the Time of Sale Disclosure Package and the Final
Offering Memorandum, all outstanding shares of capital stock of the
subsidiaries are owned free and clear of any perfected security interest or any
other security interests, claims, liens or encumbrances.

     (iv) The statements under “Part I—Item 3 Legal Proceedings” in the Company’s
Annual Report Form 10-K for the year ended June 30, 2006, under “Part I—Item 1 Legal
Proceedings” in the Company’s Quarterly Report on Form 10-Q for the quarter ended
September 30, 2006, under “Part I—Item 1 Legal Proceedings” in the Company’s
Quarterly Report on Form 10-Q for the quarter ended December 31, 2006, and under
“Part I—Item 1 Legal Proceedings” in the Company’s Quarterly Report on Form 10-Q for
the quarter ended March 31, 2007, in each case incorporated by reference in the Time
of Sale Disclosure Package and the Final Offering Memorandum, insofar as such
statements summarize legal matters, agreements, documents or proceedings discussed
therein, are accurate and fair summaries of such legal matters, agreements,
documents or proceedings; and

     (v) Each of the documents incorporated by reference in the Time of Sale
Disclosure Package and in the Final Offering Memorandum, when they became effective
or were filed with the Commission, as the case may be, conformed in all material
respects with the requirements of the Securities Act or the Exchange Act, as
applicable; and such counsel has no reason to believe that any of such documents,
when such document became effective or were so filed, as the case may be, contained
an untrue statement of a material fact or omitted to state a material fact necessary
to make the statements therein, in the light of the circumstances under which they
were made, not misleading.

19

 

          In rendering such opinion, such counsel may rely (x) as to matters involving the application
of laws of any jurisdiction other than the States of Delaware and New York or the Federal laws of
the United States, to the extent deemed proper and specified in such opinion, upon the opinion of
other counsel of good standing whom he believes to be reliable and who are satisfactory to counsel
for the Initial Purchasers and (y) as to matters of fact, to the extent deemed proper, on
certificates of responsible officers of the Company and public officials. References to the Final
Offering Memorandum in this paragraph (c) shall also include any supplements thereto at the Closing
Date.

          (d) On the Closing Date, the Initial Purchasers shall have received from Shearman & Sterling
LLP, counsel for the Initial Purchasers, such opinion or opinions, dated the Closing Date and
addressed to the Initial Purchasers, with respect to the issuance and sale of the Securities, the
Time of Sale Disclosure Package, the Final Offering Memorandum (together with any supplement
thereto) and other related matters as the Initial Purchasers may reasonably require, and the
Company shall have furnished to such counsel such documents as they request for the purpose of
enabling them to pass upon such matters.

          (e) Since the date of the most recent financial statements included in the Time of Sale
Disclosure Package and the Final Offering Memorandum (exclusive of any supplement thereto), there
has been no material adverse effect on the condition (financial or otherwise), prospects, earnings,
business or properties of the Company and its subsidiaries, taken as a whole,
whether or not arising from transactions in the ordinary course of business, except as set
forth in or contemplated by the Time of Sale Disclosure Package and the Final Offering Memorandum
(exclusive of any supplement thereto); and the Company shall have furnished to the Representatives
a certificate of the Company, signed by the Chairman of the Board or the President and the
principal financial or accounting officer of the Company, dated the Closing Date, to the effect
that the signers of such certificate have carefully examined the Time of Sale Disclosure Package,
the Final Offering Memorandum, any supplements to the Final Offering Memorandum and this Agreement
and that:

     (i) The representations and warranties of the Company in this Agreement are
true and correct on and as of the Closing Date with the same effect as if made on
the Closing Date and the Company has complied with all the agreements and satisfied
all the conditions on its part to be performed or satisfied at or prior to the
Closing Date;

     (ii) Since the date of the most recent financial statements included in the
Time of Sale Disclosure Package and the Final Offering Memorandum (exclusive of any
supplement thereto), there has been no material adverse effect on the condition
(financial or otherwise), prospects, earnings, business or properties of the Company
and its subsidiaries, taken as a whole, whether or not arising from transactions in
the ordinary course of business, except as set forth in or contemplated in the Time
of Sale Disclosure Package and the Final Offering Memorandum (exclusive of any
supplement thereto).

20

 

          (f) The Representatives shall have received, at the time this Agreement is executed and at the
Closing Date, a letter dated the date hereof or the Closing Date, as the case may be, in form and
substance satisfactory to the Representatives from Ernst & Young LLP, independent public
accountant, containing statements and information of the type customarily included in accountants’
comfort letters to underwriters with respect to the financial statements and certain financial
information contained in the Time of Sale Disclosure Package and the Final Offering Memorandum.
The Representatives shall also have received, at the time this agreement is executed, letters dated
the date hereof, in form and substance satisfactory to the Representatives from each of KPMG LLP,
BDO Dunwoody LLP and Mr. Robert Wilson, independent public accountants, containing statements and
information of the type customarily included in accountants’ comfort letters to underwriters with
respect to the financial statements and certain financial information contained in the Time of Sale
Disclosure Package and the Final Offering Memorandum.

          (g) Subsequent to the date of this Agreement, there shall not have been any decrease in the
rating of any of the Company’s debt securities by any “nationally recognized statistical rating
organization” (as defined for purposes of Rule 436(g) under the Securities Act) or any notice given
of any intended or potential decrease in any such rating or of a possible change in any such rating
that does not indicate the direction of the possible change.

          (h) On or after the Time of Sale there shall not have occurred any of the following: (i) a
suspension or limitation in trading of the Company’s Common Stock by the Commission or NASDAQ; (ii)
a general suspension or general limitation in trading or setting of
minimum prices occurs on the New York Stock Exchange or NASDAQ; (iii) a banking moratorium
declared by either the Federal or New York State authorities; or (iii) an outbreak or escalation of
hostilities, declaration by the United States of a national emergency or war, or other calamity or
crisis the effect of which on the financial markets is such as to make it, in the sole judgment of
the Representatives, impractical or inadvisable to proceed with the offering or delivery of the
Securities as contemplated by the Time of Sale Disclosure Package (exclusive of any supplement
thereto).

          (i) On or prior to the Closing Date, the Representatives and counsel for the Initial
Purchasers shall have been furnished such further information, certificates and documents as the
Representatives or counsel for the Initial Purchasers may reasonably request.

          8B. Conditions to Purchase of Optional Securities. In the event that the Initial
Purchasers exercise their option provided in Section 3(b) hereof to purchase all or any portion of
the Optional Securities on any Option Closing Date that is after the Closing Date, the obligations
of the several Initial Purchasers to purchase the applicable Optional Securities shall be subject
to the conditions specified in Section 8A hereof being met as of such Optional Closing date except
that, at the applicable Optional Closing Date, the Representatives shall have received:

	 	(a)	 	A certificate, dated such Option Closing Date, to the effect
set forth in, and signed by two of the officers specified in, Section 8A(e)
hereof, except that the references in such certificate to the Closing Date
shall be changed to refer to such Option Closing Date.

21

 

	 	(b)	 	The favorable opinion of Pepper Hamilton LLP, counsel for the
Company, and of Roy Hibberd, Senior vice President and General Counsel of the
Company, each in form and substance satisfactory to the Representatives and
dated such Option Closing Date, relating to the Optional Securities to be
purchased on such Option Closing Date and otherwise to the same effect as the
respective opinions referred to in subdivisions (b) and (c) of Section 8A
hereof.
	 
	 	(c)	 	The favorable opinion of Shearman & Sterling LLP, counsel for
the Initial Purchasers, in form and substance satisfactory to the
Representatives and dated such Option Closing Date, relating to the Optional
Securities to be purchased on such Option Closing Date and otherwise to the
same effect as the opinion required by subdivision (d) of Section 8A hereof,
and the Company shall have furnished to such counsel such documents as they
request for the purpose of enabling them to pass upon such matters.
	 
	 	(d)	 	A letter dated such Option Closing Date in form and substance
satisfactory to the Representatives from Ernst & Young LLP, independent public
accountant, containing statements and information of the type customarily
included in accountants’ comfort letters to underwriters with respect to the
financial statements and certain financial information contained in the Time of
Sale Disclosure Package and the Final Offering Memorandum.

          If any of the conditions specified in Sections 8A or 8B hereof shall not have been fulfilled
when and as provided in this Agreement, or if any of the opinions and certificates mentioned above
or elsewhere in this Agreement shall not be reasonably satisfactory in form and substance to the
Representatives and counsel for the Initial Purchasers, this Agreement and all obligations of the
Initial Purchasers hereunder may be canceled at, or at any time prior to, the Closing Date, or any
Option Closing Date, as the case may be, by the Representatives. Notice of such cancellation shall
be given to the Company in writing or by telephone or facsimile confirmed in writing.

          9. Reimbursement of Initial Purchasers’ Expenses. If the sale of the Securities
provided for herein is not consummated because any condition to the obligations of the Initial
Purchasers set forth in Section 8A or Section 8B hereof is not satisfied, because of any
termination pursuant to subdivision (i) of Section 8A hereof or because of any refusal, inability
or failure on the part of the Company to perform any agreement herein or comply with any provision
hereof other than by reason of a default by any of the Initial Purchasers, the Company will
reimburse the Initial Purchasers on demand for all out-of-pocket expenses (including reasonable
fees and disbursements of counsel) that shall have been incurred by it in connection with the
proposed purchase and sale of the Securities.

          10. Indemnification and Contribution.

          (a) The Company agrees to indemnify and hold harmless the Initial Purchasers, the directors,
officers, employees and agents of the Initial Purchasers and each

22

 

person who controls any of the
Initial Purchasers within the meaning of either the Securities Act or the Exchange Act against any
and all losses, claims, damages or liabilities, joint or several, to which they or any of them may
become subject under the Securities Act, the Exchange Act or other Federal or state statutory law
or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon an untrue statement or alleged
untrue statement of a material fact contained in the Time of Sale Disclosure Package, the Final
Offering Memorandum, or any amendment or supplement thereto (including any documents filed under
the Exchange Act and deemed to be incorporated by reference into the Final Offering Memorandum),
the Pricing Term Sheet, any Supplemental Offering Materials or any other written information used
by or on behalf of the Company in connection with the offer or sale of the Securities (or any
amendment or supplement to the foregoing), or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated therein or necessary to
make the statements therein not misleading, and agrees to reimburse each such indemnified party, as
incurred, for any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability or action; provided,
however, that the Company will not be liable in any such case to the extent that any such
loss, claim, damage or liability arises out of or is based upon any such untrue statement or
alleged untrue statement or omission or alleged omission made therein in reliance upon and in
conformity with written information furnished to the Company by or on behalf of the Initial
Purchasers through the Representatives specifically for inclusion therein. The Company agrees and
acknowledges that the statements set forth in the last paragraph of the cover page regarding
delivery of the Securities and, under the heading “Plan of Distribution,” the ninth paragraph
related to stabilization and covering transactions in the Preliminary Offering Memorandum and the
Final Offering Memorandum constitute the only information furnished to the Company by or
on behalf of the Initial Purchasers through the Representatives in accordance with the
immediately preceding sentence. This indemnity agreement will be in addition to any liability
which the Company may otherwise have.

          (b) The Initial Purchasers agree, severally and not jointly, to indemnify and hold harmless
the Company, each of its directors, each of its officers, and each person who controls the Company
within the meaning of either the Securities Act or the Exchange Act to the same extent as the
foregoing indemnity from the Company to the Initial Purchasers, but only with reference to
information relating to the Initial Purchasers furnished to the Company in writing by the Initial
Purchasers through the Representatives expressly for use in the Time of Sale Disclosure Package,
the Final Offering Memorandum, or any amendment or supplement thereto, the Pricing Term Sheet or
any Supplemental Offering Materials. This indemnity agreement will be in addition to any liability
which any Initial Purchaser may otherwise have. The Company agrees and acknowledges that the
statements set forth in the last paragraph of the cover page regarding delivery of the Securities
and, under the heading “Plan of Distribution,” the ninth paragraph related to stabilization and
covering transactions in the Preliminary Offering Memorandum and the Final Offering Memorandum
constitute the only information furnished in writing by or on behalf of the Initial Purchasers in
accordance with the second preceding sentence.

          (c) Promptly after receipt by an indemnified party under this Section 10 of notice of the
commencement of any action, such indemnified party will, if a claim in respect

23

 

thereof is to be
made against the indemnifying party under this Section 10, notify the indemnifying party in writing
of the commencement thereof; but the failure so to notify the indemnifying party (i) will not
relieve it from liability under paragraphs (a) or (b) of this Section 10, as the case may be,
unless and to the extent it did not otherwise learn of such action and such failure results in the
forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any
event, relieve the indemnifying party from any obligations to any indemnified party other than the
indemnification obligations provided in paragraph (a) or (b) above, as the case may be. The
indemnifying party shall be entitled to appoint counsel of the indemnifying party’s choice at the
indemnifying party’s expense to represent the indemnified party in any action for which
indemnification is sought (in which case the indemnifying party shall not thereafter be responsible
for the fees and expenses of any separate counsel retained by the indemnified party or parties
except as set forth below); provided, however, that such counsel shall be
satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to
appoint counsel to represent the indemnified party in an action, the indemnified party shall have
the right to employ separate counsel (including local counsel), and the indemnifying party shall
bear the reasonable fees, costs and expenses of such separate counsel if (i) the use of counsel
chosen by the indemnifying party to represent the indemnified party would present such counsel with
a conflict of interest, (ii) the actual or potential defendants in, or targets of, any such action
include both the indemnified party and the indemnifying party and the indemnified party shall have
reasonably concluded that there may be legal defenses available to it and/or other indemnified
parties which are different from or additional to those available to the indemnifying party, (iii)
the indemnifying party shall not have employed counsel satisfactory to the indemnified party to
represent the indemnified party within a reasonable time after notice of the institution of such
action or (iv) the indemnifying party shall authorize the indemnified party to employ separate
counsel at the expense of the indemnifying party. It is understood that no
indemnifying party shall, in connection with any proceeding or related proceeding in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to
any local counsel) for all indemnified parties and that all such fees and expenses shall be
reimbursed as they are incurred. An indemnifying party will not, without the prior written consent
of the indemnified parties, settle or compromise or consent to the entry of any judgment with
respect to any pending or threatened claim, action, suit or proceeding in respect of which
indemnification or contribution may be sought hereunder (whether or not the indemnified parties are
actual or potential parties to such claim or action) unless such settlement, compromise or consent
includes an unconditional release of each indemnified party from all liability arising out of such
claim, action, suit or proceeding and does not include a statement as to or an admission of fault,
culpability or failure to act by or on behalf of the indemnified party.

          (d) In the event that the indemnity provided in paragraph (a) or (b) in this Section 10, as
the case may be, is unavailable to or insufficient to hold harmless an indemnified party for any
reason, the Company and each Initial Purchaser, severally and not jointly, agrees to contribute to
the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably
incurred in connection with investigating or defending same) (collectively “Losses”) to which the
Company and any one or more of the Initial Purchasers may be subject in such proportion as is
appropriate to reflect the relative benefits received by the Company, on the one hand, and by the
Initial Purchasers, on the other hand, from the offering of the Securities. If the allocation
provided by the immediately preceding sentence is unavailable for any reason, the

24

 

Company and the
Initial Purchasers, severally and not jointly, shall contribute in such proportion as is
appropriate to reflect not only such relative benefits received but also the relative fault of the
Company, on the one hand, and of the Initial Purchasers, on the other hand, in connection with the
statements or omissions which resulted in such Losses as well as any other relevant equitable
considerations. Benefits received by the Company shall be deemed to be equal to the total net
proceeds from the offering (before deducting expenses) received by each of them, and benefits
received by the Initial Purchasers shall be deemed to be equal to the total underwriting discounts
and commissions, in each case as set forth on the cover page of the Final Offering Memorandum.
Relative fault shall be determined by reference to, among other things, whether any untrue or any
alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information provided by the Company on the one hand or the Initial Purchasers on
the other, the intent of the parties and their relative knowledge, access to information and
opportunity to correct or prevent such untrue statement or omission. The Company and the Initial
Purchasers agree that it would not be just and equitable if contribution were determined by pro
rata allocation or any other method of allocation which does not take account of the equitable
considerations referred to above. Notwithstanding the provisions of this paragraph (d), no person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. For purposes of this Section 10, each person who controls an Initial Purchaser
within the meaning of either the Securities Act or the Exchange Act and each director, officer,
employee and agent of an Initial Purchaser shall have the same rights to contribution as such
Initial Purchaser, and each person who controls the Company within the meaning of either the
Securities Act or the Exchange Act, each officer of the Company who shall have signed the
Registration Statement and each director of the Company shall have the same rights to contribution
as the Company, subject in each case to the applicable terms and conditions of this paragraph (d).
Notwithstanding the provisions of this Section 10, in no event shall the
Initial Purchasers be required to contribute any amount in excess of the underwriting discount
or commission applicable to the Securities purchased by the Initial Purchasers hereunder. The
obligations of the Initial Purchasers to contribute to this paragraph (d) are several in proportion
to the respective aggregate principal amount of Securities to be purchased by each of the Initial
Purchasers hereunder and not joint.

          11. Default by One or More of the Initial Purchasers. If any one or more of the
several Initial Purchasers shall fail or refuse to purchase Securities that it or they have agreed
to purchase hereunder on the Closing Date, and the aggregate number of Securities that such
defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase does
not exceed 10% of the aggregate number of the Securities to be purchased on such date, the other
Initial Purchasers shall be obligated, severally, in the proportions that the amount of Securities
set forth opposite their respective names on Schedule I bears to the aggregate number of Securities
set forth opposite the names of all such non-defaulting Initial Purchasers, or in such other
proportions as may be specified by the Initial Purchasers with the consent of the non-defaulting
Initial Purchasers, to purchase the Securities which such defaulting Initial Purchaser or Initial
Purchasers agreed but failed or refused to purchase on such date. If any one or more of the
Initial Purchasers shall fail or refuse to purchase Securities and the aggregate number of
Securities with respect to which such default occurs exceeds 10% of the aggregate number of
Securities to be purchased on the Closing Date, and arrangements satisfactory to the Initial

25

 

Purchasers and the Company for the purchase of such Securities are not made within 48 hours after
such default, this Agreement shall terminate without liability of any party to any other party
except that the provisions of Section 5, Section 7 and Section 10 shall at all times be effective
and shall survive such termination, but only as to such non-defaulting Initial Purchasers. In any
such case either the Initial Purchasers on the one hand or the Company on the other hand shall have
the right to postpone the Closing Date, as the case may be, but in no event for longer than seven
days in order that any changes to the Final Offering Memorandum or any other documents or
arrangements deemed necessary or desirable may be effected.

          12. Representations and Indemnities to Survive. The respective agreements,
representations, warranties, indemnities and other statements of the Company or its officers and of
the Initial Purchasers set forth in or made pursuant to this Agreement will remain in full force
and effect, regardless of any investigation made by or on behalf of any Initial Purchaser or the
Company or any of the officers, directors, employees, agents or controlling persons referred to in
Section 9 hereof, and will survive delivery of and payment for the Securities. The provisions of
Sections 8 and 9 hereof shall survive the termination or cancellation of this Agreement.

          13. Notices. All communications hereunder will be in writing and effective only on
receipt, and, if sent to the Initial Purchasers, will be mailed or delivered to Wachovia Capital
Markets, LLC, 375 Park Avenue, 4th Floor, New York, New York 10152, Attention: Lear Beyer, Equity
Syndicate Department; or, if sent to the Company, will be mailed, delivered or telefaxed to it at
Dollar Financial Corp., 1436 Lancaster Avenue, Berwyn, Pennsylvania 19312-1288 Attention: Donald F.
Gayhardt, President (telefax no. 610-296-0991) and confirmation to: Brian M. Katz, Esq., Pepper
Hamilton LLP, 3000 Two Logan Square, 18th and Arch Streets, Philadelphia, PA 19103-2799; or in each
case to such other address as the person to be notified may have requested in writing. Any party
to this Agreement may change such address for notices by sending to the parties to this Agreement
written notice of a new address for such purpose.

          14. Successors. This Agreement will inure to the benefit of and be binding upon the
parties hereto and their respective successors and the officers, directors, employees, agents and
controlling persons referred to in Section 9 hereof, and no other person will have any right or
obligation hereunder.

          15. No Advisory or Fiduciary Responsibility. The Company acknowledges and agrees
that: (i) the purchase and sale of the Securities pursuant to this Agreement, including the
determination of the public offering price of the Securities and any related discounts and
commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and
the Initial Purchasers, on the other hand, and the Company is capable of evaluating and
understanding and understand and accept the terms, risks and conditions of the transactions
contemplated by this Agreement; (ii) in connection with each transaction contemplated hereby and
the process leading to such transaction the Initial Purchasers are and have been acting solely as
principals and are not the financial advisors, agents or fiduciaries of the Company or its
affiliates, stockholders, creditors or employees or any other party; (iii) the Initial Purchasers
have not assumed and will not assume an advisory, agency or fiduciary responsibility in favor of
the Company with respect to any of the transactions contemplated hereby or the process leading
thereto (irrespective of whether the Initial Purchasers have advised or are currently advising the

26

 

Company on other matters) and the Initial Purchasers do not have any obligation to the Company with
respect to the offering contemplated hereby except the obligations expressly set forth in this
Agreement; (iv) the Initial Purchasers and their affiliates may be engaged in a broad range of
transactions that involve interests that differ from those of the Company and that the Initial
Purchasers have no obligation to disclose any of such interests by virtue of the transactions
contemplated hereby; and (v) the Initial Purchasers have not provided any legal, accounting,
regulatory or tax advice with respect to the offering contemplated hereby and the Company has
consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed
appropriate.

          16. Applicable Law. This Agreement will be governed by and construed in accordance
with the laws of the State of New York applicable to contracts made and to be performed within the
State of New York.

          17. Counterparts. This Agreement may be signed in one or more counterparts, each of
which shall constitute an original and all of which together shall constitute one and the same
agreement.

          18. Headings. The section headings used herein are for convenience only and shall not
affect the construction hereof.

27

 

Please sign and return to the Company the enclosed duplicates of this letter whereupon this letter
will become a binding agreement between the Company and the Initial Purchasers in accordance with
its terms.

	 	 	 	 	 
	 	Very truly yours,

Dollar Financial Corp.

 	 
	 	By:  	/s/ Randall Underwood
 	 
	 	 	Name:  	Randall Underwood 	 
	 	 	Title:  	Executive Vice President and

Chief Financial Officer 	 
	 

Confirmed as of the date first

above mentioned.

Wachovia Capital Markets, LLC

Bear, Stearns & Co. Inc.

Acting as Representatives of the

several Initial Purchasers named in

the attached Schedule I.

By: Wachovia Capital Markets, LLC

	 	 	 	 	 
	By:

	 	/s/ Mary Louise Guttman
	 	 
	 

	 	 	 	 
	 

	 	Name: Mary Louise Guttman	 	 
	 

	 	Title: Senior Vice President	 	 
	 
	 	 	 	 
	By: Bear, Stearns & Co. Inc.	 	 
	 
	 	 	 	 
	By:

	 	/s/ Robert Aberman	 	 
	 

	 	 	 	 
	 

	 	Name: Robert Aberman	 	 
	 

	 	Title: Senior Managing Director	 	 

28

 

SCHEDULE I

	 	 	 
	 	 	Aggregate Principal
	 	 	Amount of Initial
	Initial Purchasers	 	Securities to be Purchased
	Wachovia Capital Markets, LLC
	 	$78,750,000
	Bear, Stearns & Co. Inc.
	 	$61,250,000
	Jefferies & Company, Inc.
	 	$17,500,000
	JMP Securities LLC
	 	$17,500,000
	Total
	 	$175,000,000

I-1

 

SCHEDULE II

Supplemental Offering Materials

None.

II-1

 

SCHEDULE III

Pricing Term Sheet

III-1

 

SCHEDULE IV

Directors and Executive Officers to Sign Lock-Up Agreements

Melissa Soper

David Golub

Paul Mildenstein

Clive Kahn

John J. Gavin

Patti Smith

Norman Miller

Donald Gayhardt

Kenneth Schwenke

Roy W. Hibberd

David R. Jessick

Jeffrey Weiss

William Athas

Peter Sokolowski

Randy Underwood

IV-1

 

SCHEDULE V

Form of Opinion of Counsel for the Company Under Section 8A(b)

V-1

 

EXHIBIT A

List of Covered Domestic Subsidiaries

	 	 	 
	Covered Guarantors	 	State of Incorporation
	Check Mart of Florida, Inc.
	 	Delaware
	Check Mart of Pennsylvania, Inc.
	 	Pennsylvania
	DFG Canada, Inc.
	 	Delaware
	DFG International, Inc.
	 	Delaware
	DFG World, Inc.
	 	Delaware
	Dollar Financial Insurance Corp.
	 	Pennsylvania
	Financial Exchange Company of Ohio, Inc.
	 	Delaware
	Financial Exchange Company of Pennsylvania, Inc.
	 	Pennsylvania
	Financial Exchange Company of Pittsburgh, Inc.
	 	Delaware
	Financial Exchange Company of Virginia, Inc.
	 	Delaware
	Monetary Management Corporation of Pennsylvania
	 	Delaware
	Monetary Management of California, Inc.
	 	Delaware
	Monetary Management of Maryland, Inc.
	 	Delaware
	Monetary Management of New York, Inc.
	 	New York
	MoneyMart, Inc.
	 	Delaware
	Pacific Ring Enterprises, Inc.
	 	California
	PD Recovery, Inc.
	 	Pennsylvania
	We The People USA, Inc.
	 	Delaware
	We The People LLC
	 	Delaware

A-1

 

EXHIBIT B

Form of Lock-Up Letter Agreement

June __, 2007

WACHOVIA CAPITAL MARKETS, LLC

BEAR, STEARNS & CO. INC.

As Representatives of the Initial Purchasers

c/o Wachovia Capital Markets, LLC

One Wachovia Center

301 South College Street

Charlotte, North Carolina 28288-0604

          Re:      Proposed Offering by Dollar Financial Corp.

Ladies and Gentlemen:

          The undersigned, an officer and/or director of Dollar Financial Corp., a Delaware corporation
(the “Company”), understands that Wachovia Capital Markets, LLC and Bear, Stearns & Co. Inc., as
representatives of the several Initial Purchasers named in the Purchase Agreement (in such
capacity, the “Representatives”), propose to enter into a Purchase Agreement (the “Purchase
Agreement”) with the Company providing for the offering (the “Offering”), pursuant to Rule 144A
under the Securities Act of 1933, as amended (the “Securities Act”) of Senior Convertible Notes
due 2027 of the Company (the “Firm Securities”) and the grant by the Company to the Initial
Purchasers of the option to purchase additional Senior Convertible Notes due 2027 (the “Optional
Securities”). The Firm Securities, together with the Optional Securities, are collectively
referred to as the “Securities”. In recognition of the benefit that such an offering will confer
upon the undersigned as an officer and/or director of the Company and a holder of either equity or
derivative securities of the Company, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the undersigned agrees with each Initial
Purchaser that, during a period of 60 days from the date of the Purchase Agreement (the “Lock-Up
Period”), the undersigned will not, without the prior written consent of Wachovia Capital Markets,
LLC or Bear, Stearns & Co. Inc., directly or indirectly, (i) offer, pledge, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly,
any shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) or any
securities convertible into or exercisable or exchangeable for Common Stock (collectively with the

B-1

 

Common Stock, the “Lock-Up Securities”), or (ii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of the
Lock-Up Securities, whether any such transaction described in clause (i) or (ii) above is to be
settled by delivery of Common Stock or other such securities, in cash or otherwise, whether such
Lock-Up Securities are now owned or hereafter acquired by the undersigned or with respect to which
the undersigned has or hereafter acquires the power of disposition, or (iii) make any demand of, or
exercise any right with respect to, the filing of any registration statement under the Securities
Act, with respect to any of the foregoing.

          Notwithstanding anything herein to the contrary, the foregoing shall not be deemed to restrict
the undersigned with respect to (1) the exercise of options to acquire shares of Common Stock,
including the sale of any shares of Common Stock to pay for the exercise price or any withholding
tax obligation with respect thereto, (2) the disposition or sale of shares of Lock-Up Securities to
the Company, (3) the disposition or sale of shares of Common Stock pursuant to a written trading
plan or agreement with a broker designed to comply with Rule 10b5-1(c) promulgated pursuant to the
Securities Exchange Act of 1934, as amended (“Rule 10b5-1 Plan”) that has been established as of
the date of this Agreement, provided that any such Rule 10b5-1 Plan shall not be amended or
modified prior to the expiration of the Lock-Up Period, and (4) the entering into of any Rule
10b5-1 Plan, provided that any such Rule 10b5-1 Plan shall specify that any sales of Common Stock
sold for the undersigned’s benefit pursuant to the Rule 10b5-1 Plan shall not occur prior to the
expiration of the Lock-Up Period.

          Notwithstanding the foregoing, and subject to the conditions below, the undersigned may
transfer the Lock-Up Securities without the prior written consent of Wachovia Capital Markets, LLC
and Bear, Stearns & Co. Inc., provided that (1) the Representatives receive a signed lock-up
agreement for the balance of the Lock-Up Period from each donee, trustee, distributee, or
transferee, as the case may be, and (2) except with respect to clause (iii) below, any such
transfer shall not involve a disposition for value:

          (i) as a bona fide gift or gifts; or

          (ii) to any immediate family member or any trust or other entity for the direct or indirect
benefit of the undersigned or the immediate family of the undersigned (for purposes of this lock-up
agreement, “immediate family” shall mean any relationship by blood, marriage or adoption, not more
remote than first cousin); or

          (iii) to the undersigned’s affiliates or any entity under common control with the undersigned
or to any investment fund or other entity controlled or managed by the undersigned.

          The undersigned also agrees and consents to the entry of stop transfer instructions with the
Company’s transfer agent and registrar against the transfer of the Lock-Up Securities except in
compliance with the foregoing restrictions.

          If the Company notifies you in writing that it does not intend to proceed with the offering of
the Securities, or for any reason following the execution of the Purchase Agreement it shall be
terminated prior to the time of purchase in accordance with the terms of the Purchase

B-2

 

Agreement, this letter agreement shall be terminated and the undersigned shall be released
from its obligations hereunder.

Very truly yours,

Signature:                                                            

Print Name:                                                            

B-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]